



     <!-- SiteMaker 7.0 CMS (TM)
     Code created by Medseek, Inc. 2028 Village Lane, Solvang CA 93463.
     Phone 1-888 MEDSEEK. email info@medseek.com. http://www.medseek.com 
     (c) 1999-2010 Medseek, Inc. All rights reserved.-->
    













	
	
	 
	 
	 
	 

	
	
	
	

	
	

	
	

	
	

	
	

	
	

	
	


	
	

	
	

	
	
	
	
	

	
	

	
	

	
	

	
	

	
		
		
	
		

	
		

	
		

	
		

	 
	 
	 
	 

	
	
	
	
	
	
	
	
		
	

	
	 
	
	
	
	
	
	

	
	
	
	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	
	
	
	
	
	
	
	
	

	
	

	
	

	
	
	
	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	
	
	

	
	

	
	
	
	
	

	
	

	
	

	
	

		
	
	
	
	
	
	
	
	
	
	

	
	

	
	

	

	
	

	
	

	
	

	
	

	
	

	
	
	
	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	

	
	
	
	
	

	
	

	
	

	
	

	
	

	
	

	
		
		
	
		

	
		

	
		

	
		
	
	
		
		
	
		
	
	
		
	
	
	
		
	
	
	
	
	
	
	
	

	
	
	
	
	
		
		
			

		
		
		
		
		
		
		
		
		
		
		
		
		
		

		
			
		
		 
		
		
		
		

		
		
		
		
		
		
		
		
		
		

		
		
		
		

		

		
		
		

			
				
			
		
		
		
		
		

		
		
		
		
		
		
		
			

		
		
		
		
				
		
		
		
				
		
			
		

		
		
		
		
		
		
	
		
			
			
			
		
		
		
	
		
			
			
		

		
		
		
		
			

		

		
		
		

			
				
			
		
		
		
		
		

		
		
		
		
		
		

		
					
						
		
		
				
		
		
		
		
		
				
		
		

		
		
		
		
		
		
		
		
			
			
				
			
		
		
		
		
		
			
			
		
		
		
		
		
			
			
		

		
		
		
			
			
		
		
		

		
			

			
		
		

		
		

		
				
		 
		
			
		
		
		

		
			
			
		
		
		
			

		

		
		
		
		

		
		

		
		
		
		
		
		
		
		
		
		

		
		

		
	
	
	
	




	
	
	

	
	
	
	
	
	
	
	
	
	

	
	


	
	
		
			
		
	
	
	
	
	
		
			
		
	
	
	
	
	

 


	
	
	
		



		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		

		
		

		
		
		
		

		

		
		
		

			
				
			
		
		
		
		
		

		
		
		
		
		
		
		
			

		
		
		
		
				
		
		
		
				
		
			
		

		
		
		
		
		
		
	
		
			
			
			
		
		
		
	
		
			
			
		

		
		
		
		
			

		

		
		
		

			
				
			
		
		
		
		
		

		
		
		
		
		
		

		
					
						
		
		
				
		
		
		
		
		
				
		
		

		
		
		
		
		
		
		
		
			
			
				
			
		
		
		
		
		
			
			
		
		
		
		
		
			
			
		

		
		
		
			
			
		
		
		

		
			

			
		
		

		
		

		
				
		 
		
			
		
		
		

		
			
			
			
		
		
			

		

		
		
		
	
		

		
		

		
		
		
		
			
		
		
		
			

		
		

		
		

		
		
		
		
		
		
		
			
				

		
		
		
		

		

		
		
		

			
				
			
		
		
		
		
		

		
		
		
		
		
		

		
		
		
		
				
		
		
		
				
		
			
		

		
		
		
		
		
		
	
		
			
			
			
		
		
		
	
		
			
			
		

		
		
		
		
			

		

		
		
		

			
				
			
		
		
		
		
		

		
		
		
		
		
		

		
					
						
		
		
				
		
		
		
		
		
				
		
		

		
		
		
		
		
		
		
		
			
			
				
			
		
		
		
		
		
			
			
		
		
		
		
		
			
			
		

		
		
		
			
			
		
		
		

		
			

			
		
		

		
		

		
				
		 
		
			
		
		
		

				
			
		
		

		
		
		
		
			

		
		

		
		

		
		
		
		
		
		
		
		

		
		
		
		
		
		
			

		
		

		
		

		
		
		
		
		
		
		
			
				

		
		
		
		
		
		
		
		
		
		
		
		
		
		

		
			
		
		 
		
		
		
		

		
		
		
		
		
		
		
		
		
		

		
		
		
		

		

		
		
		

			
				
			
		
		
		
		
		

		
		
		
		
		
		
		
			

		
		
		
		
				
		
		
		
				
		
			
		

		
		
		
		
		
		
	
		
			
			
			
		
		
		
	
		
			
			
		

		
		
		
		
			

		

		
		
		

			
				
			
		
		
		
		
		

		
		
		
		
		
		

		
					
						
		
		
				
		
		
		
		
		
				
		
		

		
		
		
		
		
		
		
		
			
			
				
			
		
		
		
		
		
			
			
		
		
		
		
		
			
			
		

		
		
		
			
			
		
		
		

		
			

			
		
		

		
		

		
				
		 
		
			
		
		
		

		
			
			
		
		
		
			

		

		
		
		
		

		
		

		
		
		
		
		
		
		
		
		
		

		

		

		
		
		
		
		
		
		
		
		
		
		
		

		
			
		
		

		
		
		
		


		
			

		

		
		
		

	
		
		
		
		

		


		
		
		
		


 

		
	

	
	
		










































	

 







	<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">
	<HTML>



 
	



 
	

	




	<HEAD>
	<TITLE>Clinical Trials at St. Mary</TITLE>
	<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
	<meta name="description" content="">
	<meta name="keywords" content="">
	<style type="text/css">
		@import url(default.css);
	</style>
	
	
				
<script type="text/javascript">
//<!--
var ns4 = (document.layers);
var ie  = (document.all);
var ie4 = (ie && !document.getElementById);
var ie5 = (ie && document.getElementById);
var ns6 = (!ie && document.getElementById);

var aryMoused = new Array();
var aryLayerMoused = new Array();
var aryMoImages = new Array();
var imageList = new Array();
var runMouseOvers = true;
var TimerID = null;
var iLimit = 25;
var itmp = 0;

var nbTime = 100;
var nbTimes = 2;
var nbThisLoc = 325;
var aryLayerNames = new Array();
var aryNavBarLayerInfo = new Array();
var aryNavBarLayers = new Array();

var registeredObjects = new Array();
var viz = "hide";

function MOImage() {
	var arg = MOImage.arguments;
	this.ptrImage = BillzNavBarMM_findObj(arg[0]);
	this.imageMO = new Image();
	this.imageMO.src = arg[1];
	this.HTMLname = arg[0];
	this.Moused = false;
	this.OriginalSrc = '';
	return true;
}

function BillzImagePreload() {
	// 0) html image name 1) mo image src 2)image Name for rollover key (rollover may have multiple mos for one html Image) 
	var arg = BillzImagePreload.arguments;
	nbImagePreload(arg[0], arg[1], arg[2]);
}

function nbImagePreload(img_name, mo_img_src, rollover_key_img_name) {
	var imageKey = (rollover_key_img_name.length > 0) ? rollover_key_img_name : img_name;
	imageList[imageList.length] = imageKey;
	if (!(aryMoImages[imageKey])) aryMoImages[imageKey] = new MOImage(img_name, mo_img_src);
}

function BillzMouseover() {
	var arg = null;
	if (runMouseOvers) {		
		arg = BillzMouseover.arguments; //args 0)ImageName 1)OriginalSrc 2)array index (caller imagename)		
		nbMouseover(arg[0], arg[1], arg[2]);
	}
	return true;
}
// args 1) ImageName 2) OriginalSrc 3) array index (caller imagename)
function nbMouseover(img_name, orig_src, img_key) {
	var imageKey = null;
	var o = null;
	if (runMouseOvers) 
	{				
		imageKey = (img_key.length > 0) ? img_key : img_name;
		if (!(aryMoImages[imageKey].ptrImage)) aryMoImages[imageKey].ptrImage = BillzNavBarMM_findObj(img_name);		
		if (aryMoImages[imageKey] && (o = aryMoImages[imageKey].ptrImage)) {
			aryMoImages[imageKey].OriginalSrc = orig_src;
			aryMoImages[imageKey].Moused = true;
			o.src = aryMoImages[imageKey].imageMO.src;
		}
	}
	return true;
}

var NavBarTempOnload = null;
if (window.onload && window.onload != null) NavBarTempOnload = window.onload;

function FullyLoaded() {
	if (NavBarTempOnload != null) NavBarTempOnload();
	runMouseOvers = true;
	return true;
}

function BillzMouseOutTimer() {
	return nbMouseOutTimer();
}

function nbMouseOutTimer() {
	if (TimerID) clearTimeout(TimerID);
	TimerID = setTimeout("nbLayerRestore()",5000);
	return true;
}

function RestoreAll() {
	nbMouseoverRestore();
	nbLayerRestore();
	return true;
}

function BillzMouseoverRestore() {
	return nbMouseoverRestore();
}

function nbMouseoverRestore() {
	var i = 0;
	var o = null;
	if (runMouseOvers) {
		for (i = 0; i < imageList.length; i++) {
			if (aryMoImages[imageList[i]].Moused && (o = aryMoImages[imageList[i]].ptrImage)) {
				o.src = aryMoImages[imageList[i]].OriginalSrc;
				aryMoImages[imageList[i]].Moused = false;
			}
		}
	}
	return true;
}

function BillzLayerRestore() {
	return nbLayerRestore();
}

function nbLayerRestore() {
	var i = 0;
	for (i = 0; i < aryLayerNames.length; i++) {
		if (!aryNavBarLayerInfo[aryLayerNames[i]].isDefault) BillzNavBarRestoreLayers(aryLayerNames[i]);	
	}
	return true;
}

function BillzArrayPushUnique(aryArray, varNewElement) { //only pushes if unique value
	var pushIt = true;
	var i = 0;
	for (i = 0; i < aryArray.length && pushIt; i++) {
		pushIt = (varNewElement != aryArray[i]);
	}
	if (pushIt) BillzArrayPush(aryArray, varNewElement);
	return pushIt;
}

function BillzArrayPush(aryArray, varNewElement) { //Implement Array Push 'cause IE cant handle it
	aryArray[aryArray.length] = varNewElement;
	return true;
}
function BillzArrayPop(aryArray) { //Implement Array Pop 'cause IE cant handle it before 5.5
	var varItemToPop = null;
	if (aryArray[aryArray.length - 1]) {
		varItemToPop = aryArray[aryArray.length - 1];
		aryArray[aryArray.length] = null;
	}
	return varItemToPop;
}

function getDivRef(id) {
	var divref;
	if(ns4) divref = document.layers[id];
	else if(ie4) divref = document.all[id];
	else if(ie5 || ns6) divref = document.getElementById(id);	
	return divref;
}

//v3.0 name changed to avoid clash with possible other JS in content, this function complements of MM Dreamweaver
function NavBarSwapRollover(swapimage,defaultimage,imageID) {
	if(imageID.length > 0 && document.getElementById(imageID))
	{
		if(swapimage.length > 0) 
			document.getElementById(imageID).src = "images/" + swapimage;
		else
			document.getElementById(imageID).src = "images/" + defaultimage;		
	}
}
function BillzNavBarMM_findObj(n, d) {
	var p,i,x;
	if (ns6) x = document.getElementById(n);
	else {		
		if (registeredObjects[n]) return registeredObjects[n];
		if (!(d)) d = document;
		try {
			p = n.indexOf("?");
		}
		catch(e) {
			p = 0;
		}
		if (p > 0 && parent.frames.length) {
			d = parent.frames[n.substring(p+1)].document;
			n = n.substring(0,p);
		}
		if (!(x = d[n]) && d.all) x = d.all[n];	
		for (i = 0; !x && i < d.forms.length; i++) {
			x = d.forms[i][n];
		}
		for (i=0; !x && d.layers && i < d.layers.length; i++) {
			if (d.layers[i].id.indexOf("external_") == -1) x = BillzNavBarMM_findObj(n, d.layers[i].document);	
		}
		registeredObjects[n] = x;
	}				
	return x;
}

function BillzArrayContains() {
	var arg = BillzArrayContains.arguments;
	var foundit = false;
	var i = 0;
	for (i = 0; i < arg[0].length && !foundit; i++) {
		foundit = (arg[1] == arg[0][i]);
	}
	return foundit;
}

function NavBarRegisterLayer() {
	var arg = NavBarRegisterLayer.arguments;
	var n = arg[0];
	var d = arg[1];
	var mo = false;
	var o = null;
	if (arg[2] && arg[2] == 'MOutLayer') mo = true;
	else mo = false;
	
	if (!(BillzArrayContains(aryLayerNames, n))) {
		if (o = BillzNavBarMM_findObj(n)) {
			aryNavBarLayers[n] = o;
			BillzArrayPushUnique(aryLayerNames, n);
			aryNavBarLayerInfo[n] = new NavBarLayer(n, d, mo);
		}
	}
	return true;
}

function BillzNavBarMM_showHideLayers() {
	//v3.0 name changed, this function complements of MM Dreamweaver with customizations by Bill Heller
	var i = 0;
	var x = "";
	var obj = null;
	var v = null;
	var p = null;
	var args = BillzNavBarMM_showHideLayers.arguments;
	
	if (args[args.length - 1] != "menu") nbMouseOutTimer();
	for (i = 0; i < (args.length - 2); i += 3) {
		if (!aryNavBarLayers[args[i]]) {
			x = (args[i + 2] == 'show') ? 'hide' : 'show';
			NavBarRegisterLayer(args[i], x);
		}
		if ((obj = aryNavBarLayers[args[i]]) != null) {
			v = args[i + 2];
			aryNavBarLayerInfo[args[i]].isDefault = false;
			if (args[args.length - 1] == "restore") v = (v == 'show') ? 'hide' : 'show';
			
			if (obj.style) obj.style.visibility = (v == 'show') ? 'visible' : ((v == 'hide') ? 'hidden' : v);
			else obj.visibility = v;
		}
	}
	return true;
}

function BillzNavBarRestoreLayers() {
	var i = 0;
	var x = "";
	var obj = null;
	var v = null;
	var p = null;
	var args = BillzNavBarRestoreLayers.arguments;
	for (i = 0; i < (args.length); i++) {
		if (obj = aryNavBarLayers[args[i]]) {
			v = aryNavBarLayerInfo[args[i]].defaultVisibility;
			if (obj.style) {
				obj = obj.style;
				v = (v == 'show' ) ? 'visible' : ((v == 'hide') ? 'hidden' : v);
			}
			obj.visibility = v;
			if (!aryNavBarLayerInfo[args[i]].MOutLayer) aryNavBarLayerInfo[args[i]].isDefault = true;			
		}
	}
	return true;
}

function NavBarLayer() {
	var arg = NavBarLayer.arguments;
	this.defaultVisibility = arg[1];
	this.isDefault = true;
	this.MOutLayer = arg[2];
	return true;
}

function BillzNavMove() {
	return nbNavMove();
}

function nbNavMove() {
	var thisl = null;
	var otherl = null;
	if (thisl = BillzNavBarMM_findObj("nbScrollLayer")) {
		if (thisl.style) {
			thisl = thisl.style;
			viz = "hidden";
		} 
		thisl.top = nbThisLoc -= 3;
		if (nbThisLoc < -750) {
			nbThisLoc = 325;
			nbTimes--;
		}
	}
	if (nbTimes <= 0) {
		otherl = BillzNavBarMM_findObj("BillzLayer");
		otherl.visibility = viz;
	} else {
		setTimeout("nbNavMove()", nbTime);
	}	
	return true;
}

function NavBar_openadmin() {
	window.open('admin/','SiteAdmin','height=screen.availheight,width=screen.availwidth,scrollbars=1,toolbar=0,directories=0,status=0,menubar=0,resizable=1');
	return true;
}

window.onload = FullyLoaded;
//-->
</script>
					
<script type="text/javascript">
//<!--
				
nbImagePreload('colleaquelog_1_1','images/colleaquelog_on.gif', '');

//-->
</script>
<script type="text/javascript">
//<!--
function NavBar_setCookie(cookievalue,navVersion,linkID) 
{	
	var cookiename = "SLIDINGTABLE_NAVBAR" + navVersion;
	var cookieVersionname = "SLIDINGTBL_NAVBAR_VERSION";
	var cookieClear = "SLIDINGTBL_NAVBAR_CLEARCOOKIES";	
	document.cookie = cookieClear.toUpperCase() + "=false";
	if(cookievalue.length > 0)
		document.cookie = cookiename.toUpperCase() + "=" + escape(cookievalue);
	if(navVersion.length > 0)	
		document.cookie = cookieVersionname.toUpperCase() + "=" + navVersion;	
	if(linkID.length > 0)
		NavBar_setPLinkIDCookie(linkID,navVersion);		
}
function NavBar_setoLevelIDCookie(cookievalue,linkID,navVersion) 
{
	var name = "SLIDINGTBL_NAVBAR_OLEVELID";		
	if(cookievalue.length > 0)
		document.cookie = name.toUpperCase() + "=" + escape(cookievalue);	
	if(linkID.length > 0)
		NavBar_setPLinkIDCookie(linkID,navVersion);	
	if(navVersion.length > 0)	
		document.cookie = "SLIDINGTBL_NAVBAR_VERSION=" + navVersion;		
}
function NavBar_setPLinkIDCookie(linkID,navVersion)
{	
	document.cookie = "SLIDINGTBL_NAVBAR_PLINKID=" + linkID;	
	if(navVersion.length > 0)	
		document.cookie = "SLIDINGTBL_NAVBAR_VERSION=" + navVersion;
}
function NavBar_deleteCookie() 
{
	// first we'll split this cookie up into name/value pairs
	// note: document.cookie only returns name=value, not the other components
	var check_name = "SLIDINGTABLE_NAVBAR";	
	var a_all_cookies = document.cookie.split( ';' );
	var a_temp_cookie = '';
	var cookie_name = '';
	var cookie_value = '';
	var b_cookie_found = false; // set boolean t/f default f	

	document.cookie = "SLIDINGTBL_NAVBAR_VERSION=0";	
	document.cookie = "SLIDINGTBL_NAVBAR_OLEVELID=";	
	for (i = 0; i < a_all_cookies.length; i++)
	{		
		a_temp_cookie = a_all_cookies[i].split( '=' );			
		cookie_name = a_temp_cookie[0].replace(/^\s+|\s+$/g, '');
		
		//expire all cookies for every slidingTable_navbar intances.			
		if (cookie_name.toUpperCase().indexOf(check_name) == 0)		
			document.cookie = cookie_name.toUpperCase() + "=";			 	
	}	
}
		
//-->
</script>
			
				
<script type="text/javascript">
//<!--
function NavBar_setCookie(cookievalue,navVersion,linkID) 
{	
	var cookiename = "SLIDINGTABLE_NAVBAR" + navVersion;
	var cookieVersionname = "SLIDINGTBL_NAVBAR_VERSION";
	var cookieClear = "SLIDINGTBL_NAVBAR_CLEARCOOKIES";	
	document.cookie = cookieClear.toUpperCase() + "=false";
	if(cookievalue.length > 0)
		document.cookie = cookiename.toUpperCase() + "=" + escape(cookievalue);
	if(navVersion.length > 0)	
		document.cookie = cookieVersionname.toUpperCase() + "=" + navVersion;	
	if(linkID.length > 0)
		NavBar_setPLinkIDCookie(linkID,navVersion);		
}
function NavBar_setoLevelIDCookie(cookievalue,linkID,navVersion) 
{
	var name = "SLIDINGTBL_NAVBAR_OLEVELID";		
	if(cookievalue.length > 0)
		document.cookie = name.toUpperCase() + "=" + escape(cookievalue);	
	if(linkID.length > 0)
		NavBar_setPLinkIDCookie(linkID,navVersion);	
	if(navVersion.length > 0)	
		document.cookie = "SLIDINGTBL_NAVBAR_VERSION=" + navVersion;		
}
function NavBar_setPLinkIDCookie(linkID,navVersion)
{	
	document.cookie = "SLIDINGTBL_NAVBAR_PLINKID=" + linkID;	
	if(navVersion.length > 0)	
		document.cookie = "SLIDINGTBL_NAVBAR_VERSION=" + navVersion;
}
function NavBar_deleteCookie() 
{
	// first we'll split this cookie up into name/value pairs
	// note: document.cookie only returns name=value, not the other components
	var check_name = "SLIDINGTABLE_NAVBAR";	
	var a_all_cookies = document.cookie.split( ';' );
	var a_temp_cookie = '';
	var cookie_name = '';
	var cookie_value = '';
	var b_cookie_found = false; // set boolean t/f default f	

	document.cookie = "SLIDINGTBL_NAVBAR_VERSION=0";	
	document.cookie = "SLIDINGTBL_NAVBAR_OLEVELID=";	
	for (i = 0; i < a_all_cookies.length; i++)
	{		
		a_temp_cookie = a_all_cookies[i].split( '=' );			
		cookie_name = a_temp_cookie[0].replace(/^\s+|\s+$/g, '');
		
		//expire all cookies for every slidingTable_navbar intances.			
		if (cookie_name.toUpperCase().indexOf(check_name) == 0)		
			document.cookie = cookie_name.toUpperCase() + "=";			 	
	}	
}
		
//-->
</script>
			
				
<script type="text/javascript">
//<!--
function NavBar_setCookie(cookievalue,navVersion,linkID) 
{	
	var cookiename = "SLIDINGTABLE_NAVBAR" + navVersion;
	var cookieVersionname = "SLIDINGTBL_NAVBAR_VERSION";
	var cookieClear = "SLIDINGTBL_NAVBAR_CLEARCOOKIES";	
	document.cookie = cookieClear.toUpperCase() + "=false";
	if(cookievalue.length > 0)
		document.cookie = cookiename.toUpperCase() + "=" + escape(cookievalue);
	if(navVersion.length > 0)	
		document.cookie = cookieVersionname.toUpperCase() + "=" + navVersion;	
	if(linkID.length > 0)
		NavBar_setPLinkIDCookie(linkID,navVersion);		
}
function NavBar_setoLevelIDCookie(cookievalue,linkID,navVersion) 
{
	var name = "SLIDINGTBL_NAVBAR_OLEVELID";		
	if(cookievalue.length > 0)
		document.cookie = name.toUpperCase() + "=" + escape(cookievalue);	
	if(linkID.length > 0)
		NavBar_setPLinkIDCookie(linkID,navVersion);	
	if(navVersion.length > 0)	
		document.cookie = "SLIDINGTBL_NAVBAR_VERSION=" + navVersion;		
}
function NavBar_setPLinkIDCookie(linkID,navVersion)
{	
	document.cookie = "SLIDINGTBL_NAVBAR_PLINKID=" + linkID;	
	if(navVersion.length > 0)	
		document.cookie = "SLIDINGTBL_NAVBAR_VERSION=" + navVersion;
}
function NavBar_deleteCookie() 
{
	// first we'll split this cookie up into name/value pairs
	// note: document.cookie only returns name=value, not the other components
	var check_name = "SLIDINGTABLE_NAVBAR";	
	var a_all_cookies = document.cookie.split( ';' );
	var a_temp_cookie = '';
	var cookie_name = '';
	var cookie_value = '';
	var b_cookie_found = false; // set boolean t/f default f	

	document.cookie = "SLIDINGTBL_NAVBAR_VERSION=0";	
	document.cookie = "SLIDINGTBL_NAVBAR_OLEVELID=";	
	for (i = 0; i < a_all_cookies.length; i++)
	{		
		a_temp_cookie = a_all_cookies[i].split( '=' );			
		cookie_name = a_temp_cookie[0].replace(/^\s+|\s+$/g, '');
		
		//expire all cookies for every slidingTable_navbar intances.			
		if (cookie_name.toUpperCase().indexOf(check_name) == 0)		
			document.cookie = cookie_name.toUpperCase() + "=";			 	
	}	
}
		
//-->
</script>
			</HEAD>
 

<html>

<body bgcolor="#FFFFFF" leftmargin="0" topmargin="0" marginwidth="0" marginheight="0" style="scrollbar-face-color: #006299" "scrollbar-arrow-color: #006299">
<table width="100%" border="0" cellpadding="0" cellspacing="0">
  <tr> 
    <td width="1%" rowspan="4" valign="top"><table width="100%" border="0" cellpadding="0" cellspacing="0">
        <tr> 
          <td width="1%" valign="top"><img src="images/tablespacer.gif"></td>
        </tr>
      </table>
	</td>
    <td width="99%" valign="top"><table width="100%" border="0" cellpadding="0" cellspacing="0">
        <tr> 
          <td width="1%" valign="top"><a href="default.cfm"><img src="images/logo_home.gif" border="0"></a></td>
          <td width="98%" valign="top"><table width="100%" border="0" cellpadding="0" cellspacing="0">
              <tr> 
                <td width="1%" valign="top"><img src="images/beforesearch.gif"></td>
                <td width="98%" align="middle" valign="middle">


	<style name="text/css" class="search">		
		td.search {background-color: transparent; background-image: URL(images/clear.gif); font-family: verdana,arial; font-weight: 700; font-size: 10px; font-color: 000000;}
				
	</style>
<script type="text/javascript" src="http://bur-ms-sm6-02.medseek.com/sm_FormValidation.js"></script>
		<table border="0" cellpadding="0" cellspacing="0" background="" align= "middle" class="search">		
		<form action="body.cfm?id=555571" method="post" onSubmit="return sm_ValidateForm(this);">
		<input type="hidden" name="action" value="list">	
		<input type="hidden" name="search_areas_id" value="">	
		<input type="hidden" name="includewhat" value="">
		<input type="hidden" name="keywords_required" value="You must enter a keyword to search.">	
			<tr class="search">							
				
					<td class="search"><img src="images/searchbutton.gif" width="53" height="21" alt="" border="0"></td>
				
				
					<td class="search"><input type="text" name="keywords" size="16" border="0" value="Search Intranet"></td>
							
				
					<td class="search"><input type="IMAGE" src="images/gobutton.gif" border="0" width="20" height="21" style="border:0px;"></td>
				
			</tr>
		</form>
		</table>
	 
</td>
              </tr>
              <tr> 
                <td width="100%" colspan="2" valign="top" style="background-image: url(images/topnavtile.gif); background-repeat: repeat-x; background-position: top left;"> 
                                   
										<table width="100%" border="0" cellpadding="0" cellspacing="0">
										<tr>
											<td width="520" valign="top" id="navigationTop" style="background-image: url(images/topnavbkgrd.gif); background-repeat: no-repeat; background-position: top left;">
												

<script type="text/javascript">
<!--

function DHTMLNavBar_configureCookie(linkID) {
	// first we'll split this cookie up into name/value pairs
	// note: document.cookie only returns name=value, not the other components
	var check_name = "SLIDINGTABLE_NAVBAR";
	var a_all_cookies = document.cookie.split( ';' );
	var a_temp_cookie = '';
	var cookie_name = '';
	var cookie_value = '';
	var b_cookie_found = false; // set boolean t/f default f

	document.cookie = "SLIDINGTBL_NAVBAR_VERSION=0";
	document.cookie = "SLIDINGTBL_NAVBAR_OLEVELID=";
	if(linkID.length)
		DHTMLNavBar_setPLinkIDCookie(linkID);

	for (i = 0; i < a_all_cookies.length; i++)
	{
		a_temp_cookie = a_all_cookies[i].split( '=' );
		cookie_name = a_temp_cookie[0].replace(/^\s+|\s+$/g, '');

		//expire all cookies for every slidingTable_navbar intances.
		if (cookie_name.toUpperCase().indexOf(check_name) == 0)
			document.cookie = cookie_name.toUpperCase() + "=";
	}
}
function DHTMLNavBar_setPLinkIDCookie(linkID){
	document.cookie = "SLIDINGTBL_NAVBAR_PLINKID=" + linkID;
}
function findPosY(obj) {
	var curtop = 0;
	if (obj.offsetParent)
	{
		while (obj.offsetParent)
		{
			curtop += obj.offsetTop
			obj = obj.offsetParent;
		}
	}
	else if (obj.y)
	{
		curtop += obj.y;
	}
	return curtop;
}
var aryDHTMLLayerMoused = new Array();
var DHTMLrunMouseOvers = false;
var aryDHTMLMoImages = new Array();
var DHTMLimageList = new Array();
var DHTMLTimerID=null;
var itmp=0;

function DHTMLMOImage() {
	var a = DHTMLMOImage.arguments;
	this.ptrImage = DHTMLNavBarMM_findObj(a[0]);
	this.imageMO = new Image();
	this.imageMO.src = a[1];
	this.HTMLname = a[0];
	this.Moused = false;
	this.OriginalSrc = '';
}
// 0) html image name 1) mo image src 2)image Name for rollover key (rollover may have multiple mos for one html Image)
function DHTMLNavBarImagePreload() {
	var arg = DHTMLNavBarImagePreload.arguments;
	imageKey = (arg[2])?arg[2]:arg[0];
	DHTMLimageList[DHTMLimageList.length] = imageKey;
	if(!(aryDHTMLMoImages[imageKey]))
		aryDHTMLMoImages[imageKey] = new DHTMLMOImage(arg[0],arg[1]);
}
function DHTMLNavBarMouseover() {
	var a = null;
	var imageKey = null;
	var o = null;
	if (DHTMLrunMouseOvers)
	{
		//args 0)ImageName 1)OriginalSrc 2)array index (caller imagename)
		a = DHTMLNavBarMouseover.arguments;
		imageKey = (a[2])?a[2]:a[0];
		if(!(aryDHTMLMoImages[imageKey].ptrImage))
			aryDHTMLMoImages[imageKey].ptrImage = DHTMLNavBarMM_findObj(a[0]);
		if(aryDHTMLMoImages[imageKey] && (o = aryDHTMLMoImages[imageKey].ptrImage))
		{
			aryDHTMLMoImages[imageKey].OriginalSrc = a[1];
			aryDHTMLMoImages[imageKey].Moused = true;
			o.src = aryDHTMLMoImages[imageKey].imageMO.src;
		}
	}
}

var DHTMLNavBarTemponload = null;
if (window.onload && window.onload != null)
	DHTMLNavBarTemponload = window.onload;

function DHTMLFullyLoaded() {
	if (DHTMLNavBarTemponload != null)
		DHTMLNavBarTemponload();
	DHTMLrunMouseOvers = true;
	return true;
}
function DHTMLNavBarMouseOutTimer() {
	if(DHTMLTimerID)
		clearTimeout(DHTMLTimerID);
	DHTMLTimerID = setTimeout("DHTMLNavBarLayerRestore()",5000);
}
function DHTMLRestoreParent(layername) {
	for(var i=0;i < aryDHTMLLayerNames.length;i++)
	{
		if(!aryDHTMLNavBarLayerInfo[aryDHTMLLayerNames[i]].isDefault)
		{
			if(!(aryDHTMLLayerNames[i] == layername) && aryDHTMLLayerNames[i].indexOf("grand") == -1)
				DHTMLNavBarRestoreLayers(aryDHTMLLayerNames[i]);
		}
	}
}
function DHTMLRestoreAll() {
	DHTMLNavBarMouseoverRestore();
	DHTMLNavBarLayerRestore();
}
function DHTMLNavBarMouseoverRestore() {
	var i = 0;
	var o = null;
	if (DHTMLrunMouseOvers)
	{
		for (var i=0; i < DHTMLimageList.length; i++)
		{
			if (aryDHTMLMoImages[imageList[i]].Moused && (o = aryDHTMLMoImages[imageList[i]].ptrImage)) {
				o.src = aryDHTMLMoImages[imageList[i]].OriginalSrc;
				aryDHTMLMoImages[imageList[i]].Moused = false;
			}
		}
	}
	return true;
}
function DHTMLNavBarLayerRestore() {
	for(var i=0;i < aryDHTMLLayerNames.length;i++)
	{
		if(!aryDHTMLNavBarLayerInfo[aryDHTMLLayerNames[i]].isDefault)
			DHTMLNavBarRestoreLayers(aryDHTMLLayerNames[i]);
	}
}
function DHTMLNavBarArrayPushUnique(aryArray, varNewElement){
	//only pushes if unique value
	var pushIt = true;
	for (var i=0;i < aryArray.length && pushIt;i++)
	{
		pushIt = (varNewElement!=aryArray[i]);
	}
	if(pushIt)
		DHTMLNavBarArrayPush(aryArray, varNewElement);

	return pushIt;
}
function DHTMLNavBarArrayPush(aryArray, varNewElement) {
	//Implement Array Push 'cause IE cant handle it
	aryArray[aryArray.length]=varNewElement;
}
function DHTMLNavBarArrayPop(aryArray) {
	//Implement Array Pop 'cause IE cant handle it before 5.5
	var varItemToPop = null;
	if(aryArray[aryArray.length-1]) {
		varItemToPop = aryArray[aryArray.length-1];
		aryArray[aryArray.length]=null;
	}
	return varItemToPop;
}

var registeredObjects = new Array();
//v3.0 name changed to avoid clash with possible other JS in content, this function complements of MM Dreamweaver
function DHTMLNavBarMM_findObj(n, d) {
	x = document.getElementById(n);
	return x;
}

var DHTMLNavBarTime         = 100;
var DHTMLNavBarTimes        = 2;
var DHTMLNavBarmoveDistance = 1;
var DHTMLNavBarThisLoc      = 325;
var aryDHTMLLayerNames      = new Array();
var aryDHTMLNavBarLayerInfo = new Array();
var aryDHTMLNavBarLayers    = new Array();

function DHTMLNavBarArrayContains()	{
	var a = DHTMLNavBarArrayContains.arguments;
	var foundit = false;
	for(var i=0; i < a[0].length && !foundit; i++)
	{
		foundit = (a[1]==a[0][i]);
	}
	return foundit;
}

function DHTMLNavBarRegisterLayer()	{
	var a = DHTMLNavBarRegisterLayer.arguments;
	var n = a[0];
	var d = a[1];
	if(a[2] && a[2] == 'MOutLayer')
		var mo = true;
	else
		var mo = false;

	if(!(DHTMLNavBarArrayContains(aryDHTMLLayerNames,n)))
	{
		if(o = DHTMLNavBarMM_findObj(n))
		{
			aryDHTMLNavBarLayers[n] = o;
			DHTMLNavBarArrayPushUnique(aryDHTMLLayerNames,n);
			aryDHTMLNavBarLayerInfo[n] = new DHTMLNavBarLayer(n,d,mo);
		}
	}
}

// v3.0 name changed, this function complements of MM Dreamweaver with customizations
function DHTMLNavBarMM_showHideLayers()	{
	var i,p,v,x,obj,args = DHTMLNavBarMM_showHideLayers.arguments;
	if(args[args.length-1] != "menu")
		DHTMLNavBarMouseOutTimer();
	for (var i=0; i<(args.length-2); i+=3)
	{
		if(!aryDHTMLNavBarLayers[args[i]]) {
			x = (args[i+2]=='show')?'hide':'show';
			DHTMLNavBarRegisterLayer(args[i],x);
		}
	 	if ((obj=aryDHTMLNavBarLayers[args[i]])!=null)
		{
			v = args[i+2];
			aryDHTMLNavBarLayerInfo[args[i]].isDefault = false;
	 		if(args[args.length-1] == "restore")
				v = (v=='show')?'hide':'show';
			if (obj.style)
				obj.style.visibility = (v=='show')?'visible':(v='hide')?'hidden':v;
			else
				obj.visibility = v;
		}
	}
}

// v3.0 name changed, this function complements of MM Dreamweaver with customizations
function DHTMLNavBarMM_showHideGrandLayers() {
	var i,p,v,x,obj,args = DHTMLNavBarMM_showHideGrandLayers.arguments;
	if(args[args.length-1] != "menu")
		DHTMLNavBarMouseOutTimer();
	for (var i=0; i < (args.length-2); i+=3)
	{
		if(!aryDHTMLNavBarLayers[args[i]]) {
			x = (args[i+2]=='show')?'hide':'show';
			DHTMLNavBarRegisterLayer(args[i],x);
		}
	 	if ((obj=aryDHTMLNavBarLayers[args[i]])!=null)
		{
			v = args[i+2];
			aryDHTMLNavBarLayerInfo[args[i]].isDefault = false;
	 			if(args[args.length-1] == "restore"){
				v = (v=='show')?'hide':'show';
			}
			if (obj.style)
				obj.style.visibility = (v=='show')?'visible':(v='hide')?'hidden':v;
			else
	 			obj.visibility = v;
		}
	}
}
function DHTMLNavBarRestoreLayers()	{
	var i,p,v,obj,args = DHTMLNavBarRestoreLayers.arguments;
	for (var i=0; i < (args.length); i++)
	{
	 	if (obj = aryDHTMLNavBarLayers[args[i]])
		{
			v = aryDHTMLNavBarLayerInfo[args[i]].defaultVisibility;
			var strobjid = obj.id;
			if (obj.style)
			{
				obj=obj.style;
				v=(v=='show')?'visible':(v='hide')?'hidden':v;
			}
			obj.visibility = v;
			if (!aryDHTMLNavBarLayerInfo[args[i]].MOutLayer)
				aryDHTMLNavBarLayerInfo[args[i]].isDefault=true;
		}
	}
}
function DHTMLNavBarLayer()	{
	var a = DHTMLNavBarLayer.arguments;
	this.defaultVisibility = a[1];
	this.isDefault = true;
	this.MOutLayer = a[2];
}

var viz = "hide";
function DHTMLNavBarNavMove() {
	if(thisl==DHTMLNavBarMM_findObj("DHTMLNavBarScrollLayer"))
	{
		if(thisl.style)
		{
			thisl=thisl.style;
			viz="hidden";
		}
		thisl.top = DHTMLNavBarThisLoc -= 3;
		if(DHTMLNavBarThisLoc < -750)
		{
			DHTMLNavBarThisLoc=325;
			DHTMLNavBarTimes--;
		}
	}
	if (DHTMLNavBarTimes<=0)
	{
		otherl=DHTMLNavBarMM_findObj("DHTMLNavBarLayer");
		otherl.visibility=viz;
	}
	else setTimeout("DHTMLNavBarNavMove()",DHTMLNavBarTime);
}
function DHTML_swapImgRestore()	{
 	var i,x,a=document.Sliding_sr;
 	for(var i=0; a && i < a.length && (x=a[i]) && x.oSrc; i++)
	{
		x.src = x.oSrc;
	}
}
function DHTML_preloadImages() {
 	var d=document;
 	if(d.images)
 	{
 		if(!d.Sliding_p)
			d.Sliding_p=new Array();
		var i,j=d.Sliding_p.length,a=DHTML_preloadImages.arguments;
		for(var i=0; i < a.length; i++)
		{
	 		if (a[i].indexOf("#")!=0)
			{
				d.Sliding_p[j]=new Image;
				d.Sliding_p[j++].src=a[i];
			}
		}
	}
}
function DHTML_findObj(n, d) {
	var p,i,x;
	if(!d)
		d=document;
	if((p=n.indexOf("?")) > 0 && parent.frames.length)
	{
	 	d=parent.frames[n.substring(p+1)].document;
		n=n.substring(0,p);
	}
	if(!(x=d[n]) && d.all)
		x=d.all[n];
	for (var i=0; !x && i < d.forms.length; i++)
	{
		x = d.forms[i][n];
	}
	for(var i=0; !x && d.layers && i < d.layers.length; i++)
	{
		x = DHTML_findObj(n,d.layers[i].document);
	}
	 if(!x && d.getElementById)
		x=d.getElementById(n);

	return x;
}
function DHTML_swapImage() {
	var i,j=0,x,a=DHTML_swapImage.arguments;
	document.Sliding_sr=new Array;
	for(var i=0; i < (a.length-2); i+=3)
	{
		if ((x=DHTML_findObj(a[i]))!=null)
		{
			document.Sliding_sr[j++] = x;
			if(!x.oSrc)
				x.oSrc=x.src;
			x.src = a[i+2];
		}
	}
}
function DHTMLNavBarSwapRollover(swapimage,defaultimage,imageID) {
	if(imageID.length > 0 && document.getElementById(imageID))
	{
		if(swapimage.length > 0)
			document.getElementById(imageID).src = "images/" + swapimage;
		else
			document.getElementById(imageID).src = "images/" + defaultimage;
	}
}
window.onload = DHTMLFullyLoaded;
			

//-->
</script>
			
	
<table border="0" cellpadding="0" cellspacing="0">
	<tr>
		<td valign="top">
		<div id="lryParentmain555555" class="Parentmain1"  onmouseover="DHTMLRestoreAll();DHTMLNavBarMM_showHideLayers('lyr555555','','show','menu');" onclick="DHTMLNavBar_configureCookie('555555');">
			<table border="0" class="ParentNav1" width="100%" cellpadding="0" cellspacing="0">
				<tr id="pRow555555" style="vertical-align: top; background-color: transparent;" >
					<td valign="top" style="" id="pLink555555"><a href="body.cfm?id=555555" target="" class="clMain1">About Us</a></td>
				</tr>
			</table>
			<div id="lyr555555" class="clLeft1" onMouseOut="DHTMLRestoreAll();">
				<table cellpadding="0" cellspacing="0" class="ChildNav1" border="0">
					<tr id="cRow555555_1" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555555_1"><a href="body.cfm?id=555989" target="" class="clSubb1">Quality and Patient Safety</a></td>
					</tr>
					<tr id="cRow555555_2" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555555_2"><a href="body.cfm?id=555555" target="" class="clSubb1">About St. Mary</a></td>
					</tr>
					<tr id="cRow555555_3" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555555_3"><a href="body.cfm?id=556072" target="" class="clSubb1">Heritage and History</a></td>
					</tr>
					<tr id="cRow555555_4" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555555_4"><a href="body.cfm?id=6" target="" class="clSubb1">Our Mission and Values</a></td>
					</tr>
					<tr id="cRow555555_5" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555555_5"><a href="body.cfm?id=555625" target="" class="clSubb1">A Message from the President</a></td>
					</tr>
					<tr id="cRow555555_6" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555555_6"><a href="body.cfm?id=555916" target="" class="clSubb1">St. Mary Senior Leadership</a></td>
					</tr>
				</table>
				<!--[if lte IE 6.5]>
				<div id="endTablelyr555555" style="height:1px;overflow:hidden;"></div><iframe id="Framelyr555555" frameborder="0" style="background-color:transparent;left:0px;position:absolute;top:0px;width:100%;height:90;z-index:-1;filter:mask();"></iframe>
				<![endif]-->
			</div>
		</div>
		</td>
		<td valign="top">
		<div id="lryParentmain7" class="Parentmain1"  onmouseover="DHTMLRestoreAll();DHTMLNavBarMM_showHideLayers('lyr7','','show','menu');" onclick="DHTMLNavBar_configureCookie('7');">
			<table border="0" class="ParentNav1" width="100%" cellpadding="0" cellspacing="0">
				<tr id="pRow7" style="vertical-align: top; background-color: transparent;" >
					<td valign="top" style="" id="pLink7"><a href="body.cfm?id=7" target="" class="clMain1">Directions</a></td>
				</tr>
			</table>
			<div id="lyr7" class="clLeft1" onMouseOut="DHTMLRestoreAll();">
				<table cellpadding="0" cellspacing="0" class="ChildNav1" border="0">
					<tr id="cRow7_1" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink7_1"><a href="body.cfm?id=7" target="" class="clSubb1">Driving Directions</a></td>
					</tr>
					<tr id="cRow7_2" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink7_2"><a href="body.cfm?id=95" target="" class="clSubb1">Campus Map</a></td>
					</tr>
					<tr id="cRow7_3" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink7_3"><a href="body.cfm?id=42" target="" class="clSubb1">Outreach Sites</a></td>
					</tr>
				</table>
				<!--[if lte IE 6.5]>
				<div id="endTablelyr7" style="height:1px;overflow:hidden;"></div><iframe id="Framelyr7" frameborder="0" style="background-color:transparent;left:0px;position:absolute;top:0px;width:100%;height:45;z-index:-1;filter:mask();"></iframe>
				<![endif]-->
			</div>
		</div>
		</td>
		<td valign="top">
		<div id="lryParentmain555557" class="Parentmain1"  onmouseover="DHTMLRestoreAll();DHTMLNavBarMM_showHideLayers('lyr555557','','show','menu');" onclick="DHTMLNavBar_configureCookie('555557');">
			<table border="0" class="ParentNav1" width="100%" cellpadding="0" cellspacing="0">
				<tr id="pRow555557" style="vertical-align: top; background-color: transparent;" >
					<td valign="top" style="" id="pLink555557"><a href="body.cfm?id=555557" target="" class="clMain1">Contact Us</a></td>
				</tr>
			</table>
			<div id="lyr555557" class="clLeft1" onMouseOut="DHTMLRestoreAll();">
				<table cellpadding="0" cellspacing="0" class="ChildNav1" border="0">
					<tr id="cRow555557_1" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555557_1"><a href="body.cfm?id=555557" target="" class="clSubb1">Email Us</a></td>
					</tr>
					<tr id="cRow555557_2" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555557_2"><a href="body.cfm?id=185" target="" class="clSubb1">Phone Numbers</a></td>
					</tr>
					<tr id="cRow555557_3" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555557_3"><a href="body.cfm?id=11" target="" class="clSubb1">Physician Directory</a></td>
					</tr>
				</table>
				<!--[if lte IE 6.5]>
				<div id="endTablelyr555557" style="height:1px;overflow:hidden;"></div><iframe id="Framelyr555557" frameborder="0" style="background-color:transparent;left:0px;position:absolute;top:0px;width:100%;height:45;z-index:-1;filter:mask();"></iframe>
				<![endif]-->
			</div>
		</div>
		</td>
		<td valign="top">
		<div id="lryParentmain555623" class="Parentmain1"  onmouseover="DHTMLRestoreAll();DHTMLNavBarMM_showHideLayers('lyr555623','','show','menu');" onclick="DHTMLNavBar_configureCookie('555623');">
			<table border="0" class="ParentNav1" width="100%" cellpadding="0" cellspacing="0">
				<tr id="pRow555623" style="vertical-align: top; background-color: transparent;" >
					<td valign="top" style="" id="pLink555623"><a href="body.cfm?id=555623" target="" class="clMain1">News Room</a></td>
				</tr>
			</table>
			<div id="lyr555623" class="clLeft1" onMouseOut="DHTMLRestoreAll();">
				<table cellpadding="0" cellspacing="0" class="ChildNav1" border="0">
					<tr id="cRow555623_1" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555623_1"><a href="body.cfm?id=556284" target="" class="clSubb1">Press Releases</a></td>
					</tr>
					<tr id="cRow555623_2" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555623_2"><a href="body.cfm?id=97" target="" class="clSubb1">Publications</a></td>
					</tr>
					<tr id="cRow555623_3" style="vertical-align: top; background-color: transparent;"  onmouseover="">
						<td valign="top" class="ChildNav1" style="" id="cLink555623_3"><a href="body.cfm?id=96" target="" class="clSubb1">Newsworthy Events</a></td>
					</tr>
				</table>
				<!--[if lte IE 6.5]>
				<div id="endTablelyr555623" style="height:1px;overflow:hidden;"></div><iframe id="Framelyr555623" frameborder="0" style="background-color:transparent;left:0px;position:absolute;top:0px;width:100%;height:45;z-index:-1;filter:mask();"></iframe>
				<![endif]-->
			</div>
		</div>
		</td>
	</tr>
</table>
											</td>
										</tr>
									</table>
														
														 </td>
              </tr>
            </table></td>
        </tr>
      </table>
	 </td>
  </tr>
  <tr> 
    <td width="1%" valign="top"><table width="100%" border="0" cellpadding="0" cellspacing="0">
        <tr> 
          <td width="1%" valign="top"><img src="images/bodyimage_nurses.jpg" border="0"></td>
          <td width="99%" valign="top"><table width="100%" border="0" cellpadding="0" cellspacing="0">
              <tr> 
                <td colspan="3" height="15" valign="top" bgcolor="033F62">
	<!-- Begin NavBar Output  -  Version:  v0.79a 09/30/2006  -->
	
		<!-- Begin NavBar Bar #1 Content Output... -->
		<table  border="0" cellspacing="0" cellpadding="0" onclick="NavBar_deleteCookie();">
	<tr class="">
		<td class="" valign="top" align="left"><img src="images/beforelogin.jpg" alt=""></td>
		<td class="" valign="top" align="left" title=""><a href="Javascript: void(0);"  onMouseOver="RestoreAll();nbMouseover('colleaquelog_1_1','images/colleaquelog.gif','');" onMouseOut ="nbMouseoverRestore();" onClick="NavBar_setPLinkIDCookie('555561','');window.location.href='body.cfm?id=555561&oTopID=0';" class=""><img src="images/colleaquelog.gif" border="0" alt="Colleague Login" id="colleaquelog_1_1" name="colleaquelog_1_1"></a></td>
	</tr>
</table>
	
		<!-- End NavBar Output -->
	 
</td>
              </tr>
              <tr> 
                <td width="1%" align="left" valign="top"><img src="images/bodycentertagline.jpg"></td>
                <td width="99%" colspan="2" align="left" valign="top" bgcolor="015B8D">
										<a href="body.cfm?id=555669&oTopID=0"><img src="images/careercenterbody.gif" border="0"></a></td>
              </tr>
            </table></td>
        </tr>
      </table></td>
  </tr>
  <tr> 
    <td width="98%" colspan="2" valign="top" style="background-image: url(images/bodyleftnavbkgrd.gif); background-repeat: repeat-y; background-position: top left;"><table width="100%" border="0" cellpadding="0" cellspacing="0">
        <tr> 
          <td rowspan="2" valign="top"><table width="100%" border="0" cellpadding="0" cellspacing="0">
              <tr> 
                <td width="1%" height="303" valign="top">
	<style type="text/css">
	table.mainCont1 
	{
		padding:0px;
	}
	th.clTop1 
	{
		vertical-align:top;	
	}
	table.clSub1 
	{
		width:100%;
		 padding-left:10px;
		 background-image: transparent;
	}
	table.glSub1 
	{
		width:80%;
		padding:2px;
	}
	td.pclTop1 
	{
		background-color:transparent;
		 border-bottom: 0px solid #F1FAFD;
		 padding-left: 25px;	
	}
	td.cglTop1 
	{
		text-align:right;	
	}
	A.clMain1:link 
	{
		font-family:verdana;
		 font-size:12px;
		 text-decoration:none;
		 font-weight:bold;
		 color:#696969;
		 text-align:left;
	}
	A.clMain1:visited 
	{
		font-family:verdana;
		 font-size:12px;
		 text-decoration:none;
		 font-weight:bold;
		 color:#595959;
		 text-align:left;
	}
	A.clMain1:hover 
	{
		background-color:transparent;
		 font-family:verdana;
		 font-size:12px;
		 text-decoration:hover;
		 font-weight:bold;
		 color:#0077BA;
		 text-align:left;
	}
	A.clMain1:active 
	{
		font-family:verdana;
		 font-size:12px;
		 text-decoration:none;
		 font-weight:bold;
		 color:#696969;
		 text-align:left;	
	}
	A.clSubb1:link 
	{
		font-family:verdana;
		 font-size:10px;
		 text-decoration:none;
		 font-weight:normal;
		 color:#595959;
		 text-align:left;
	}
	A.clSubb1:visited 
	{
		font-family:verdana;
		 font-size:10px;
		 text-decoration:none;
		 font-weight:normal;
		 color:#595959;
		 text-align:left;	
	}
	A.clSubb1:hover 
	{
		font-family:verdana;
		 font-size:10px;
		 text-decoration:none;
		 font-weight:normal;
		 color:#0386AE;
		 text-align:left;	
	}
	A.clSubb1:active 
	{
		font-family:verdana;
		 font-size:10px;
		 text-decoration:none;
		 font-weight:normal;
		 color:#595959;
		 text-align:left;	
	}
	A.glSubb1:link 
	{
		font-family:verdana;
		 font-size:10px;
		 text-decoration:none;
		 font-weight:normal;
		 color:#595959;
		 text-align:left;
	}
	A.glSubb1:visited 
	{
		font-family:verdana;
		 font-size:10px;
		 text-decoration:none;
		 font-weight:normal;
		 color:#595959;
		 text-align:left;	
	}
	A.glSubb1:hover 
	{
		font-family:verdana;
		 font-size:10px;
		 text-decoration:none;
		 font-weight:normal;
		 color:#0386AE;
		 text-align:left;	
	}
	A.glSubb1:active 
	{
		font-family:verdana;
		 font-size:10px;
		 text-decoration:none;
		 font-weight:normal;
		 color:#595959;
		 text-align:left;	
	}
	td.pHTMLbetween1 
	{
		padding:0px;	
	}
	td.cHTMLbetween1 
	{
		padding:0px;	
	}
	td.gHTMLbetween1 
	{
		padding:0px;	
	}
	td.pHTMLbefore1 
	{
		padding:0px;
	}
	td.cHTMLbefore1 
	{
		padding:0px;
	}
	td.gHTMLbefore1 
	{
		padding:0px;
	}
	td.pHTMLafter1 
	{
		padding:0px;
	}
	td.cHTMLafter1 
	{
		padding:0px;
	}
	td.gHTMLafter1 
	{
		padding:0px;
	}
	</style>

<script type="text/javascript">
<!--
				
//Begin: Graphic Mouseover functions
function slidingTbl_preloadImages()
{
	var d=document;
 	if(d.images)
	{
		if(!d.slidingTbl_p)
			d.slidingTbl_p=new Array();		
	}
    var i,j=d.slidingTbl_p.length,a=slidingTbl_preloadImages.arguments;
	for(i=0; i<a.length; i++)
	{
   		if (a[i].indexOf("#")!=0)
		{
			d.slidingTbl_p[j]=new Image;
			d.slidingTbl_p[j++].src=a[i];
		}
	}
}
function slidingTbl_swapImgRestore()
{
	var i,x,a=document.slidingTbl_sr;
	for(i=0; a && i<a.length && (x=a[i]) && x.oSrc; i++)
	{
		x.src = x.oSrc;
	}
}
function slidingTbl_findObj(n, d)
{
	var p,i,x;
	if(!d) d = document;
	p = n.indexOf("?");	
	x = d[n];
	if(p > 0 && parent.frames.length)	
	{
  		d = parent.frames[n.substring(p+1)].document; 
		n = n.substring(0,p);	
	}	
	if(!(x) && d.all) x = d.all[n];
	for (i=0;!x && i < d.forms.length;i++)
	{
		x = d.forms[i][n];
	}
	for(i=0;!x && d.layers && i<d.layers.length;i++)
	{
		x = slidingTbl_findObj(n,d.layers[i].document);
	}
  if(!x && d.getElementById) x = d.getElementById(n); 
  return x;
}
function slidingTbl_swapImage()
{
	var i,j=0,x,a=slidingTbl_swapImage.arguments;
	document.slidingTbl_sr = new Array;
	for(i=0;i<(a.length-2);i+=3)
	{		
		x = slidingTbl_findObj(a[i]);			
	   	if (x != null)
	   	{
			document.slidingTbl_sr[j++] = x;			
			if(!x.oSrc) x.oSrc = x.src;			
			x.src = a[i+2];			
		}
	}
}
//End: Graphic Mouseover functions
				
//Begin: Children CSS Style Mouseover functions
function cSlidingMouseout(pageID,styleID)
{
	var cRowElement = document.getElementById("cLinkTR_" + pageID + "_" + styleID);
	var cTHElement = document.getElementById("cBulletTH_" + pageID + "_" + styleID);
	var cTDElement = document.getElementById("cLinkTD_" + pageID + "_" + styleID);
	return true;
}
function cSlidingMouseover(pageID,styleID)
{
	var cRowElement = document.getElementById("cLinkTR_" + pageID + "_" + styleID);
	var cTHElement = document.getElementById("cBulletTH_" + pageID + "_" + styleID);
	var cTDElement = document.getElementById("cLinkTD_" + pageID + "_" + styleID);
	return true;
}
//END: Children CSS Style Mouseover functions
							
function slidingTbl_SetCookie1(cookievalue) 
{		
	document.cookie = "SLIDINGTABLE_NAVBAR1=" + escape(cookievalue);	
	document.cookie = "SLIDINGTBL_NAVBAR_VERSION=1";
	document.cookie = "SLIDINGTBL_NAVBAR_OLEVELID=";
}
function slidingTbl_SetoLevelIDCookie1(cookievalue)
{
	document.cookie = "SLIDINGTBL_NAVBAR_OLEVELID=" + escape(cookievalue);	
	document.cookie = "SLIDINGTBL_NAVBAR_VERSION=1";
	document.cookie = "SLIDINGTABLE_NAVBAR1=";
}
function slidingTbl_ClearCookie1() 
{			
	var check_name = "SLIDINGTABLE_NAVBAR";
	var a_all_cookies = document.cookie.split( ';' );
	var a_temp_cookie = '';
	var cookie_name = '';
	for (i = 0; i < a_all_cookies.length; i++)
	{		
		a_temp_cookie = a_all_cookies[i].split( '=' );		
		cookie_name = a_temp_cookie[0].replace(/^\s+|\s+$/g, '');		
		
		//expire all cookies for every slidingTable_navbar intances.
		if (cookie_name.toUpperCase().indexOf(check_name) == 0) 	
			document.cookie = cookie_name.toUpperCase() + "=";					 	
	}			
}
var SlidingTableTempOnload1 = null;
if(window.onload && window.onload != null)
{
	SlidingTableTempOnload1 = window.onload;
}
function initsliding1()
{
	if(SlidingTableTempOnload1 != null)	
		SlidingTableTempOnload1();
	
	document.cookie = "SLIDINGTBL_NAVBAR_VERSION=";
	slidingTbl_ClearCookie1();
slidingTbl_preloadImages('images/leftnavbullet.gif');			
	return true;
}

window.onload = initsliding1;
//-->
</script>
<table class="mainCont1" cellspacing="0" onclick="JavaScript: document.cookie='SLIDINGTBL_NAVBAR_VERSION=1';">
	<tr class="pHTMLbefore1" id="pBeforeTR_1">
		<td class="pHTMLbefore1" id="pBeforeTD_1" colspan="2"><img src="images/bodyaboveleftnav.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_555989_1">
		<th class="clTop1" id="pBulletTH_555989_1"><img src="images/leftnavbullet.gif" alt="Quality and Patient Safety" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_555989_1" onclick="slidingTbl_SetCookie1('555989^555989');"><a href="body.cfm?id=555989" class="clMain1"><img src="images/qualitybutton.jpg" alt="Quality and Patient Safety" border="0" name="pButton_555989_1" id="pButton_555989_1"></a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_555989_1">
		<td class="pHTMLbetween1" id="pBetweenTD_555989_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_556122_1">
		<th class="clTop1" id="pBulletTH_556122_1"><img src="images/leftnavbullet.gif" alt="Hospital Report 2008" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_556122_1" onclick="slidingTbl_SetoLevelIDCookie1('556122^556122');"><a href="http://www.stmaryhealthcare.org/documents/brochures/reflection2008.pdf" class="clMain1" target="_blank">Hospital Report 2008</a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_556122_1">
		<td class="pHTMLbetween1" id="pBetweenTD_556122_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_8_1">
		<th class="clTop1" id="pBulletTH_8_1"><img src="images/leftnavbullet.gif" alt="Services" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_8_1" onclick="slidingTbl_SetCookie1('8^8');"><a href="body.cfm?id=8" class="clMain1">Services</a></td>
	</tr>
	<tr class="pclTop1" id="pcLinkTR_8_1">
		<td class="pclTop1" id="pcLinkTD_8_1" colspan="2">
		<table class="clSub1" cellspacing="0">
			<tr class="clSub1" id="cLinkTR_25_1" onmouseover="cSlidingMouseover('25','1');" onmouseout="cSlidingMouseout('25','1');">
				<td class="clSub1" id="cLinkTD_25_1" onclick="slidingTbl_SetCookie1('8^8|25^25');"><a href="body.cfm?id=25" class="clSubb1">Heart and Vascular Center</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_140_1" onmouseover="cSlidingMouseover('140','1');" onmouseout="cSlidingMouseout('140','1');">
				<td class="clSub1" id="cLinkTD_140_1" onclick="slidingTbl_SetCookie1('8^8|140^140');"><a href="body.cfm?id=140" class="clSubb1">Primary Stroke Center</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_342_1" onmouseover="cSlidingMouseover('342','1');" onmouseout="cSlidingMouseout('342','1');">
				<td class="clSub1" id="cLinkTD_342_1" onclick="slidingTbl_SetCookie1('8^8|342^342');"><a href="body.cfm?id=342" class="clSubb1">Orthopedic Center</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_30_1" onmouseover="cSlidingMouseover('30','1');" onmouseout="cSlidingMouseout('30','1');">
				<td class="clSub1" id="cLinkTD_30_1" onclick="slidingTbl_SetCookie1('8^8|30^30');"><a href="body.cfm?id=30" class="clSubb1">St. Mary Regional Cancer Center</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_169_1" onmouseover="cSlidingMouseover('169','1');" onmouseout="cSlidingMouseout('169','1');">
				<td class="clSub1" id="cLinkTD_169_1" onclick="slidingTbl_SetoLevelIDCookie1('8^8|555907^169');"><a href="body.cfm?id=169" class="clSubb1">Pre-Admissions Testing</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_555731_1" onmouseover="cSlidingMouseover('555731','1');" onmouseout="cSlidingMouseout('555731','1');">
				<td class="clSub1" id="cLinkTD_555731_1" onclick="slidingTbl_SetCookie1('8^8|555731^555731');"><a href="body.cfm?id=555731" class="clSubb1">Clinical Trials at St. Mary</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_29_1" onmouseover="cSlidingMouseover('29','1');" onmouseout="cSlidingMouseout('29','1');">
				<td class="clSub1" id="cLinkTD_29_1" onclick="slidingTbl_SetCookie1('8^8|29^29');"><a href="body.cfm?id=29" class="clSubb1">Emergency Services and Trauma Center</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_137_1" onmouseover="cSlidingMouseover('137','1');" onmouseout="cSlidingMouseout('137','1');">
				<td class="clSub1" id="cLinkTD_137_1" onclick="slidingTbl_SetCookie1('8^8|137^137');"><a href="body.cfm?id=137" class="clSubb1">Surgical Services</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_52_1" onmouseover="cSlidingMouseover('52','1');" onmouseout="cSlidingMouseout('52','1');">
				<td class="clSub1" id="cLinkTD_52_1" onclick="slidingTbl_SetoLevelIDCookie1('8^8|556257^52');"><a href="body.cfm?id=52" class="clSubb1">Pain Management</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_40_1" onmouseover="cSlidingMouseover('40','1');" onmouseout="cSlidingMouseout('40','1');">
				<td class="clSub1" id="cLinkTD_40_1" onclick="slidingTbl_SetoLevelIDCookie1('8^8|555610^40');"><a href="body.cfm?id=40" class="clSubb1">Radiology Services (Medical Imaging)</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_40_1" onmouseover="cSlidingMouseover('40','1');" onmouseout="cSlidingMouseout('40','1');">
				<td class="clSub1" id="cLinkTD_40_1" onclick="slidingTbl_SetCookie1('8^8|40^40');"><a href="body.cfm?id=40" class="clSubb1">Imaging</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_39_1" onmouseover="cSlidingMouseover('39','1');" onmouseout="cSlidingMouseout('39','1');">
				<td class="clSub1" id="cLinkTD_39_1" onclick="slidingTbl_SetCookie1('8^8|39^39');"><a href="body.cfm?id=39" class="clSubb1">Women's Health</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_83_1" onmouseover="cSlidingMouseover('83','1');" onmouseout="cSlidingMouseout('83','1');">
				<td class="clSub1" id="cLinkTD_83_1" onclick="slidingTbl_SetoLevelIDCookie1('8^8|555771^83');"><a href="body.cfm?id=83" class="clSubb1">Diabetes Center</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_167_1" onmouseover="cSlidingMouseover('167','1');" onmouseout="cSlidingMouseout('167','1');">
				<td class="clSub1" id="cLinkTD_167_1" onclick="slidingTbl_SetCookie1('8^8|167^167');"><a href="body.cfm?id=167" class="clSubb1">Neurology</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_35_1" onmouseover="cSlidingMouseover('35','1');" onmouseout="cSlidingMouseout('35','1');">
				<td class="clSub1" id="cLinkTD_35_1" onclick="slidingTbl_SetCookie1('8^8|35^35');"><a href="body.cfm?id=35" class="clSubb1">Rehabilitation</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_180_1" onmouseover="cSlidingMouseover('180','1');" onmouseout="cSlidingMouseout('180','1');">
				<td class="clSub1" id="cLinkTD_180_1" onclick="slidingTbl_SetCookie1('8^8|180^180');"><a href="body.cfm?id=180" class="clSubb1">Respiratory Therapy</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_101_1" onmouseover="cSlidingMouseover('101','1');" onmouseout="cSlidingMouseout('101','1');">
				<td class="clSub1" id="cLinkTD_101_1" onclick="slidingTbl_SetCookie1('8^8|101^101');"><a href="body.cfm?id=101" class="clSubb1">Outpatient Services</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_139_1" onmouseover="cSlidingMouseover('139','1');" onmouseout="cSlidingMouseout('139','1');">
				<td class="clSub1" id="cLinkTD_139_1" onclick="slidingTbl_SetCookie1('8^8|139^139');"><a href="body.cfm?id=139" class="clSubb1">Sleep/Wake Disorders Center</a></td>
			</tr>
			<tr class="clSub1" id="cLinkTR_138_1" onmouseover="cSlidingMouseover('138','1');" onmouseout="cSlidingMouseout('138','1');">
				<td class="clSub1" id="cLinkTD_138_1" onclick="slidingTbl_SetoLevelIDCookie1('8^8|555611^138');"><a href="body.cfm?id=138" class="clSubb1">Wellness</a></td>
			</tr>
		</table>
		</td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_8_1">
		<td class="pHTMLbetween1" id="pBetweenTD_8_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_555558_1">
		<th class="clTop1" id="pBulletTH_555558_1"><img src="images/leftnavbullet.gif" alt="For Patients" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_555558_1" onclick="slidingTbl_SetCookie1('555558^555558');"><a href="body.cfm?id=555558" class="clMain1">For Patients</a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_555558_1">
		<td class="pHTMLbetween1" id="pBetweenTD_555558_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_555735_1">
		<th class="clTop1" id="pBulletTH_555735_1"><img src="images/leftnavbullet.gif" alt="Financial Assistance" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_555735_1" onclick="slidingTbl_SetCookie1('555735^555735');"><a href="body.cfm?id=555735" class="clMain1">Financial Assistance</a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_555735_1">
		<td class="pHTMLbetween1" id="pBetweenTD_555735_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_556303_1">
		<th class="clTop1" id="pBulletTH_556303_1"><img src="images/leftnavbullet.gif" alt="Online Pre-Registration" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_556303_1" onclick="slidingTbl_SetCookie1('556303^556303');"><a href="body.cfm?id=556303" class="clMain1">Online Pre-Registration</a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_556303_1">
		<td class="pHTMLbetween1" id="pBetweenTD_556303_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_555776_1">
		<th class="clTop1" id="pBulletTH_555776_1"><img src="images/leftnavbullet.gif" alt="Online Appointment Request" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_555776_1" onclick="slidingTbl_SetCookie1('555776^555776');"><a href="body.cfm?id=555776" class="clMain1">Online Appointment Request</a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_555776_1">
		<td class="pHTMLbetween1" id="pBetweenTD_555776_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_556266_1">
		<th class="clTop1" id="pBulletTH_556266_1"><img src="images/leftnavbullet.gif" alt="Online Bill Payment" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_556266_1" onclick="slidingTbl_SetCookie1('556266^556266');"><a href="body.cfm?id=556266" class="clMain1">Online Bill Payment</a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_556266_1">
		<td class="pHTMLbetween1" id="pBetweenTD_556266_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_555559_1">
		<th class="clTop1" id="pBulletTH_555559_1"><img src="images/leftnavbullet.gif" alt="Community Health" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_555559_1" onclick="slidingTbl_SetCookie1('555559^555559');"><a href="body.cfm?id=555559" class="clMain1">Community Health</a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_555559_1">
		<td class="pHTMLbetween1" id="pBetweenTD_555559_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_11_1">
		<th class="clTop1" id="pBulletTH_11_1"><img src="images/leftnavbullet.gif" alt="Physician Directory" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_11_1" onclick="slidingTbl_SetCookie1('11^11');"><a href="body.cfm?id=11" class="clMain1">Physician Directory</a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_11_1">
		<td class="pHTMLbetween1" id="pBetweenTD_11_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_555669_1">
		<th class="clTop1" id="pBulletTH_555669_1"><img src="images/leftnavbullet.gif" alt="Career Center" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_555669_1" onclick="slidingTbl_SetCookie1('555669^555669');"><a href="body.cfm?id=555669" class="clMain1">Career Center</a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_555669_1">
		<td class="pHTMLbetween1" id="pBetweenTD_555669_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_555575_1">
		<th class="clTop1" id="pBulletTH_555575_1"><img src="images/leftnavbullet.gif" alt="Calendar" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_555575_1" onclick="slidingTbl_SetCookie1('555575^555575');"><a href="body.cfm?id=555575" class="clMain1">Calendar</a></td>
	</tr>
	<tr class="pHTMLbetween1" id="pBetweenTR_555575_1">
		<td class="pHTMLbetween1" id="pBetweenTD_555575_1" colspan="2"><img src="images/leftnavspacer.gif"></td>
	</tr>
	<tr class="clTop1" id="pLinkTR_556285_1">
		<th class="clTop1" id="pBulletTH_556285_1"><img src="images/leftnavbullet.gif" alt="Support St. Mary" border="0" vspace="3" hspace="2"></th>
		<td class="clTop1" id="pLinkTD_556285_1" onclick="slidingTbl_SetoLevelIDCookie1('556285^556285');"><a href="http://www.stmaryfoundation.org" class="clMain1" target="_blank">Support St. Mary</a></td>
	</tr>
</table><br><br></td>
              </tr>
            </table></td>
          <td width="98%" colspan="4" valign="top"><table width="100%" border="0" cellpadding="0" cellspacing="8">
              <tr>
                <td width="1%" valign="top"><img src="images/contentclear.gif"><br><a href="default.cfm"><img src="images/homebutton.gif" border="0"></a><a href="javascript:history.back(1)"><img src="images/backbutton.gif" border="0"></a>
				
	<!-- Begin NavBar Output  -  Version:  v0.79a 09/30/2006  -->
	
		<!-- Begin NavBar Bar #2 Content Output... -->
		<table  border="0" cellspacing="0" cellpadding="0">
	<tr>
		<td class="" valign="top" align="left">&nbsp;<img src="images/thirdlevelbullet.gif" border="0" alt="Phases of Clinical Trials" id="Nav_Bullet_2_1" name="Nav_Bullet_2_1">&nbsp;<a href="body.cfm?id=555622"  onClick="NavBar_setCookie('8^8|555731^555731|555622^555622','1','0');" class="">Phases of Clinical Trials</a></td>
	</tr>
</table>
	
		<!-- End NavBar Output -->
	 
<br><font style="font-face:verdana; font-weight: normal; font-size: 20px; color: #005B7B;">Clinical Trials at St. Mary</font><br><br>




	
		
		
	




	<P><STRONG>
<TABLE borderColor=#2e6481 width="95%" align=center bgColor=#e9e9e9 border=3>
  <TBODY>
  <TR>
    <TD><FONT color=#000000>&nbsp;</FONT><A href="#ResearchVolunteer"       target=_self><FONT color=#000000>Becoming a Research Volunteer</FONT> 
    </A></TD></TR></TBODY></TABLE></STRONG></P>
<P><STRONG><FONT color=#2e6481>CARDIOLOGY</FONT></STRONG> </P>
<P>Presently there are no protocols at St. Mary 
<HR>

<P><FONT color=#2e6481><STRONG><FONT color=#2e6481>INTERVENTIONAL 
CARDIOLOGY</FONT></STRONG> </FONT></P><FONT color=#2e6481>
<P class=MsoNormal><FONT color=#000000><FONT face="Times New Roman"><FONT size=2><B>SMMC 05-018: </B>SYNTAX: SYNergy between pci with TAXus and cardiac 
surgery-<B></B></FONT></FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT color=#000000><FONT face="Times New Roman"><FONT   size=2>Principal Investigator:&nbsp; <st1:PersonName w:st="on">George Heyrich, MD</st1:PersonName> </FONT></FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman" color=#000000 size=2>Clinical 
  Coordinator:&nbsp; Kim Devine, <st1:PersonName w:st="on">CR</st1:PersonName> NP, C<st1:PersonName w:st="on">CR</st1:PersonName> P</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><FONT   color=#000000>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email</FONT> 
  </FONT></FONT><A href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT color=#000000><FONT face="Times New Roman"><FONT size=2><B>SMMC 07-001:</B>&nbsp; TAXUS PERSEUS<B>: </B>A 
<B><U>P</U></B>rospective <B><U>E</U></B>valuation in a <B><U>R</U></B>andomized 
Trial of the <B><U>S</U></B>afety and <B><U>E</U></B>fficacy of the 
<B><U>U</U></B>se of the TAXUS® Element<SUP>TM</SUP> Paclitaxel-Eluting Coronary 
<B><U>S</U></B>tent System for the Treatment of De Novo Coronary Artery 
Lesions</FONT></FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" color=#000000   size=2>Principal Investigator:&nbsp; George Heyrich, MD</FONT> 
  <LI class=MsoNormal><SPAN lang=IT><FONT color=#000000><FONT   face="Times New Roman"><FONT size=2>Clinical Coordinator:&nbsp; Marci Petrino, 
  RN, BSN</FONT></FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><FONT   color=#000000>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email</FONT> 
  </FONT></FONT><A href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT color=#000000><FONT face="Times New Roman"><FONT size=2><B>SMMC 06-016: </B>Closure of Patent Foramen Ovale with PFO ACCESS 
Registry</FONT></FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" color=#000000   size=2>Principal Investigator:&nbsp; <st1:PersonName w:st="on">Rakesh Shah</st1:PersonName> , MD</FONT> 
  <LI class=MsoNormal><SPAN lang=IT><FONT color=#000000><FONT   face="Times New Roman"><FONT size=2>Clinical Coordinator:&nbsp; Marci Petrino, 
  RN, BSN</FONT></FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><FONT   color=#000000>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email</FONT> 
  </FONT></FONT><A href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT color=#000000><FONT face="Times New Roman"><FONT size=2><B>SMMC 08-018</B>:&nbsp; XIENCE™ V Everolimus Eluting Coronary Stent 
System (EECSS) USA Post-Approval Study</FONT></FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" color=#000000   size=2>Principal Investigator:&nbsp; <st1:PersonName w:st="on">Rakesh Shah</st1:PersonName> , MD</FONT> 
  <LI class=MsoNormal><SPAN lang=IT><FONT color=#000000><FONT   face="Times New Roman"><FONT size=2>Clinical Coordinator:&nbsp; Marci Petrino, 
  RN, BSN</FONT></FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><FONT   color=#000000>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email</FONT> 
  </FONT></FONT><A href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT color=#000000><FONT face="Times New Roman"><FONT size=2><B>SMMC 09-014</B>:&nbsp; The <U>R</U>andomized <U>E</U>valuation of 
Recurrent <U>S</U>troke comparing <U>P</U>FO Closure to <U>E</U>stablished 
<U>C</U>urrent Standard of Care <U>T</U>reatment (“RESPECT 
TRIAL”)</FONT></FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" color=#000000   size=2>Principal Investigator:&nbsp; George Heyrich, MD</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman" color=#000000 size=2>Clinical 
  Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><FONT   color=#000000>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email</FONT> 
  </FONT></FONT><A href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P>
<P><FONT color=#2e6481><A href="mailto:mpetrino@stmaryhealthcare.org"></A></FONT></P>
<P>
<HR>

<P><STRONG>CARDIOTHORACIC / CRITICAL CARE</STRONG></P><FONT color=#000000>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-004: </STRONG>Continuous Glucose Monitoring in Hospitalized Patients 
Undergoing Intensive Insulin Therapy (CHIP)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><st1:PersonName w:st="on"></st1:PersonName></FONT><FONT   face="Times New Roman" size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, 
  BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL></FONT>
<HR>
<FONT color=#2e6481><BR><STRONG>CRITICAL CARE</STRONG> <FONT color=#000000>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-004: </STRONG>Continuous Glucose Monitoring in Hospitalized Patients 
Undergoing Intensive Insulin Therapy (CHIP)</FONT></FONT></P>
<P class=MsoNormal>&nbsp;</P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><st1:PersonName w:st="on"></st1:PersonName></FONT><FONT   face="Times New Roman" size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, 
  BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal></FONT>
<HR>
</FONT></FONT>
<P><STRONG><FONT color=#2e6481>PULMONARY / CRITICAL CARE</FONT></STRONG> </P>
<P><FONT color=#000000>Presently there are no protocols available at St. Mary 
Medical Center </FONT>
<P><FONT color=#000000>
<HR>
</FONT>
<P><FONT color=#2e6481><STRONG>ENDOCRINE&nbsp;/ DIABETES MANAGEMENT 
</STRONG></FONT><STRONG><BR></STRONG><FONT color=#2e6481><FONT color=#000000><FONT face="Times New Roman"><FONT size=2><STRONG><BR>SMMC 09-015: 
</STRONG>BOOST: N5401-3590:&nbsp; A 26-week, multinational, multi-center, 
open-labeled, two-arm, parallel, randomized, treat-to-target, efficacy and 
safety comparison of soluble insulin analogue combination (SIAC) once daily (OD) 
and insulin glargine OD both in combination with metformin in insulin-naïve 
subjects with type 2 diabetes inadequately controlled on oral antidiabetic drugs 
(OADs).</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><SPAN lang=IT><FONT   face="Times New Roman"><FONT size=2>Clinical Coordinator:&nbsp; Marci Petrino, 
  RN, BSN</FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
09-010: </STRONG>Symlin® Dose Escalation Efficacy vs. Conventional Therapy in 
Type 2 Diabetes Mellitus (DEFCon 2)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-004: </STRONG>Continuous Glucose Monitoring in Hospitalized Patients 
Undergoing Intensive Insulin Therapy (CHIP)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-002: </STRONG>NN1250-3718&nbsp;&nbsp;&nbsp;&nbsp; Begin: EASY PM:&nbsp; A 26 
wk randomized,confirmatory,controlled, open label, multicenter, treat to target 
trial comparing SIBA 200U/ml three times weekly injected in the evening and 
insulin glargine once daily in a population of insulin naïve subjects with type 
2 diabetes currently treated with OAD’S FOR INTENSIFIED 
TREATMENT</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT></FONT></P></FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><SPAN lang=IT><FONT   face="Times New Roman"><FONT size=2>Clinical Coordinator:&nbsp; Marci Petrino, 
  RN, BSN</FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
09-010: </STRONG>Symlin® Dose Escalation Efficacy vs. Conventional Therapy in 
Type 2 Diabetes Mellitus (DEFCon 2)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-004: </STRONG>Continuous Glucose Monitoring in Hospitalized Patients 
Undergoing Intensive Insulin Therapy (CHIP)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-002: </STRONG>NN1250-3718&nbsp;&nbsp;&nbsp;&nbsp; Begin: EASY PM:&nbsp; A 26 
wk randomized,confirmatory,controlled, open label, multicenter, treat to target 
trial comparing SIBA 200U/ml three times weekly injected in the evening and 
insulin glargine once daily in a population of insulin naïve subjects with type 
2 diabetes currently treated with OAD’S FOR INTENSIFIED 
TREATMENT</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT></FONT></P></FONT></FONT>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><SPAN lang=IT><FONT   face="Times New Roman"><FONT size=2>Clinical Coordinator:&nbsp; Marci Petrino, 
  RN, BSN</FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
09-010: </STRONG>Symlin® Dose Escalation Efficacy vs. Conventional Therapy in 
Type 2 Diabetes Mellitus (DEFCon 2)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-004: </STRONG>Continuous Glucose Monitoring in Hospitalized Patients 
Undergoing Intensive Insulin Therapy (CHIP)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-002: </STRONG>NN1250-3718&nbsp;&nbsp;&nbsp;&nbsp; Begin: EASY PM:&nbsp; A 26 
wk randomized,confirmatory,controlled, open label, multicenter, treat to target 
trial comparing SIBA 200U/ml three times weekly injected in the evening and 
insulin glargine once daily in a population of insulin naïve subjects with type 
2 diabetes currently treated with OAD’S FOR INTENSIFIED 
TREATMENT</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT></FONT></P></FONT></FONT>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><SPAN lang=IT><FONT   face="Times New Roman"><FONT size=2>Clinical Coordinator:&nbsp; Marci Petrino, 
  RN, BSN</FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
09-010: </STRONG>Symlin® Dose Escalation Efficacy vs. Conventional Therapy in 
Type 2 Diabetes Mellitus (DEFCon 2)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-004: </STRONG>Continuous Glucose Monitoring in Hospitalized Patients 
Undergoing Intensive Insulin Therapy (CHIP)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-002: </STRONG>NN1250-3718&nbsp;&nbsp;&nbsp;&nbsp; Begin: EASY PM:&nbsp; A 26 
wk randomized,confirmatory,controlled, open label, multicenter, treat to target 
trial comparing SIBA 200U/ml three times weekly injected in the evening and 
insulin glargine once daily in a population of insulin naïve subjects with type 
2 diabetes currently treated with OAD’S FOR INTENSIFIED 
TREATMENT</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><SPAN lang=IT><FONT   face="Times New Roman"><FONT size=2>Clinical Coordinator:&nbsp; Marci Petrino, 
  RN, BSN</FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
09-010: </STRONG>Symlin® Dose Escalation Efficacy vs. Conventional Therapy in 
Type 2 Diabetes Mellitus (DEFCon 2)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-004: </STRONG>Continuous Glucose Monitoring in Hospitalized Patients 
Undergoing Intensive Insulin Therapy (CHIP)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-002: </STRONG>NN1250-3718&nbsp;&nbsp;&nbsp;&nbsp; Begin: EASY PM:&nbsp; A 26 
wk randomized,confirmatory,controlled, open label, multicenter, treat to target 
trial comparing SIBA 200U/ml three times weekly injected in the evening and 
insulin glargine once daily in a population of insulin naïve subjects with type 
2 diabetes currently treated with OAD’S FOR INTENSIFIED 
TREATMENT</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>Principal 
  Investigator:&nbsp; <st1:PersonName w:st="on">Alan Schorr, DO</st1:PersonName> </FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2><st1:PersonName w:st="on"></st1:PersonName></FONT></FONT><FONT face="Times New Roman"   size=2>Clinical Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT></FONT><FONT size=2>
<HR>
</FONT></FONT></FONT>
<P></FONT></FONT><FONT size=2></P></FONT></P></FONT>
</FONT></FONT></FONT>
<P><STRONG><FONT color=#2e6481>EMERGENCY DEPARTMENT</FONT></STRONG></P>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><B>SMMC 
10-003:</B>&nbsp; RAMPART: the Rapid Anticonvulsant Medication Prior to Arrival 
Trial</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Principal 
  Investigator:&nbsp; Dr. Gentile (Temple University Hospital &amp; EMS)</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Research 
  Advisor:&nbsp; Kim Devine, <st1:PersonName w:st="on">CR</st1:PersonName> NP, C<st1:PersonName w:st="on">CR</st1:PersonName> P</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>
<HR>

<P><STRONG><FONT color=#2e6481>ELECTROPHYSIOLOGY</FONT></STRONG> </P>
<P><FONT color=#000000>Presently there are no protocols available at St. Mary 
Medical Center 
<P>
<HR>
</FONT></FONT>
<P><STRONG><FONT color=#2e6481>PEDIATRICS</FONT></STRONG></P><FONT color=#2e6481>
<P class=MsoNormal><FONT color=#000000><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 08-012:</STRONG>&nbsp; Primary Care Obesity Prevention: One 
or Multiple Projects</FONT></FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" color=#000000   size=2>Principal Investigator:&nbsp; Dr. Setter (University of 
  Pennsylvania)</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman" color=#000000 size=2>Research 
  Advisor:&nbsp; Kim Devine, <st1:PersonName w:st="on">CR</st1:PersonName> NP, C<st1:PersonName w:st="on">CR</st1:PersonName> P</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT color=#000000><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 09-018:</STRONG>&nbsp; National Children’s 
Study</FONT></FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" color=#000000   size=2>Principal Investigator:&nbsp; Dr. Culhane (Children’s Hospital of 
  Philadelphia)</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman" color=#000000 size=2>Research 
  Advisor:&nbsp; Kim Devine, <st1:PersonName w:st="on">CR</st1:PersonName> NP, C<st1:PersonName w:st="on">CR</st1:PersonName> P</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For additional 
  information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>
<HR>
</FONT>
<P><FONT color=#2e6481><STRONG>NEUROSURGERY</STRONG></FONT></P>
<P>Presently there are no protocols available at St. Mary Medical Center </P>
<P>
<HR>

<P><FONT color=#2e6481><STRONG>PULMONARY</STRONG></FONT></P>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><B>SMMC 
09-003:</B>&nbsp; Long-term Oxygen Treatment Trial (LOTT)</FONT></FONT></P>
<P class=MsoNormal>&nbsp;</P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Principal 
  Investigator:&nbsp; Dr. Howard Lee </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Research 
  Advisor:&nbsp; Marci Petrino, RN, BSN</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>
<HR>

<P><STRONG><FONT color=#2e6481>VASCULAR INTERVENTION</FONT></STRONG> </P><FONT color=#000000>
<P class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times"><STRONG>SMMC 
06-014:</STRONG>&nbsp; SAPPHIRE WW - P06-3603:&nbsp; Stenting and Angioplasty 
with Protection in Patients at High-Risk for Endarterectomy: Post Marketing 
Study&nbsp; </FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; David Drucker, MD</FONT> 
  <LI class=MsoNormal><SPAN lang=IT><FONT size=2><FONT   face="Times New Roman, Times">Clinical Coordinator:&nbsp; Marci Petrino, RN, 
  BSN</FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times"><STRONG>SMMC 
07-009:</STRONG>&nbsp; Carotid Stenting For High Surgical-Risk Patients; 
Evaluating Outcomes Through The Collection Of Clinical Evidence 
(“CHOICE”)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; David Drucker, MD</FONT> 
  <LI class=MsoNormal><SPAN lang=IT><FONT size=2><FONT   face="Times New Roman, Times">Clinical Coordinator:&nbsp; Marci Petrino, RN, 
  BSN</FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal></P>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times"><STRONG>SMMC 
08-019</STRONG>:&nbsp; PRICELESS: PRessure and Imaging—using the CardioMEMS 
EndoSure Sensor for Long-term follow-up after EVAR with Standard Surveillance 
(Prospective Registry)</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; David Drucker, MD</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp; Evelyn Flatley, RN, BS</FONT> 
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><STRONG></STRONG>&nbsp;</P>
<P class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times"><STRONG>SMMC 
09-005</STRONG>:&nbsp; CABANA:&nbsp; A Carotid Stenting Boston Scientific 
Surveillance Program</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; David Drucker, MD</FONT> 
  <LI class=MsoNormal><SPAN lang=IT><FONT size=2><FONT   face="Times New Roman, Times">Clinical Coordinator:&nbsp; Marci Petrino, RN, 
  BSN</FONT></FONT></SPAN> 
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT><FONT color=#000000><BR></P></FONT></P></FONT><FONT color=#000000><BR></P></FONT>
</FONT><FONT color=#000000><BR>
</FONT></FONT><FONT color=#000000><BR></FONT></FONT><FONT color=#000000><BR></FONT></FONT>
<P><FONT color=#000000>
<HR>
</FONT>
<P><FONT color=#000000><STRONG><FONT color=#2e6481>HUMANITARIAN DEVICE 
EXEMPTIONS</FONT></STRONG> <BR></FONT><FONT color=#000000><FONT color=#2e6481><FONT color=#000000></P><A href="mailto:researchinstitute@stmaryhealthcare.org"></A>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><B>SMMC 
02-009</B>:&nbsp; JOSTENT<SUP>®</SUP> Coronary Stent Graft<B> </B>and 
JOSTENT<SUP>®</SUP> GraftMaster for the treatment of free perforation, defined 
as free contrast extravasation into the pericardium, in native coronary vessels 
or saphenous vein bypass grafts = 2.75 mm in diameter</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Principal 
  Investigator:&nbsp; Ronald Fields, MD</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Research 
  Advisor:&nbsp; Kim Devine, CRNP, CCRP</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT></FONT></FONT></P></FONT></FONT></FONT></P><A href="mailto:researchinstitute@stmaryhealthcare.org"></A>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><B>SMMC 
02-009</B>:&nbsp; JOSTENT<SUP>®</SUP> Coronary Stent Graft<B> </B>and 
JOSTENT<SUP>®</SUP> GraftMaster for the treatment of free perforation, defined 
as free contrast extravasation into the pericardium, in native coronary vessels 
or saphenous vein bypass grafts = 2.75 mm in diameter</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Principal 
  Investigator:&nbsp; Ronald Fields, MD</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Research 
  Advisor:&nbsp; Kim Devine, CRNP, CCRP</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT></FONT></FONT></P></FONT></FONT></FONT>
<A href="mailto:researchinstitute@stmaryhealthcare.org"></A>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><B>SMMC 
02-009</B>:&nbsp; JOSTENT<SUP>®</SUP> Coronary Stent Graft<B> </B>and 
JOSTENT<SUP>®</SUP> GraftMaster for the treatment of free perforation, defined 
as free contrast extravasation into the pericardium, in native coronary vessels 
or saphenous vein bypass grafts = 2.75 mm in diameter</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Principal 
  Investigator:&nbsp; Ronald Fields, MD</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Research 
  Advisor:&nbsp; Kim Devine, CRNP, CCRP</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT></FONT></FONT></P><A href="mailto:researchinstitute@stmaryhealthcare.org"></A>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><B>SMMC 
02-009</B>:&nbsp; JOSTENT<SUP>®</SUP> Coronary Stent Graft<B> </B>and 
JOSTENT<SUP>®</SUP> GraftMaster for the treatment of free perforation, defined 
as free contrast extravasation into the pericardium, in native coronary vessels 
or saphenous vein bypass grafts = 2.75 mm in diameter</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Principal 
  Investigator:&nbsp; Ronald Fields, MD</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Research 
  Advisor:&nbsp; Kim Devine, CRNP, CCRP</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT></FONT></FONT>
<HR>
</FONT></FONT></FONT><A href="mailto:researchinstitute@stmaryhealthcare.org"></A>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><B>SMMC 
02-009</B>:&nbsp; JOSTENT<SUP>®</SUP> Coronary Stent Graft<B> </B>and 
JOSTENT<SUP>®</SUP> GraftMaster for the treatment of free perforation, defined 
as free contrast extravasation into the pericardium, in native coronary vessels 
or saphenous vein bypass grafts = 2.75 mm in diameter</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Principal 
  Investigator:&nbsp; Ronald Fields, MD</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Research 
  Advisor:&nbsp; Kim Devine, CRNP, CCRP</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT></FONT></FONT>
<HR>

<P><FONT color=#000000><STRONG><FONT color=#2e6481 size=4>ONCOLOGY</FONT></STRONG><BR><STRONG><FONT color=#2e6481>ANUS<BR></FONT></STRONG>Presently there are no protocols available 
at St. Mary Medical Center </FONT>
<P><FONT color=#000000></P></FONT></P></FONT>
</FONT></FONT></FONT></FONT>
<HR>
<FONT color=#2e6481><STRONG>BLADDER<BR></STRONG></FONT><FONT color=#000000>Presently there are no protocols available at St. Mary Medical 
Center </FONT>
<HR>
<STRONG><FONT color=#2e6481>BRAIN </FONT></STRONG><BR><FONT color=#000000>Presently there are no protocols available at St. Mary Medical 
Center </FONT>
<P><FONT color=#000000></P></FONT></P></FONT>
</FONT></FONT></FONT></FONT>
<HR>
<FONT color=#2e6481><STRONG>BREAST</STRONG></FONT> <FONT color=#2e6481><FONT color=#000000>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
05-003</STRONG>: &nbsp;Suppression of Ovarian Function Trial (SOFT) A Phase III 
Trial Evaluating the Role of Ovarian Function Suppression and the Role of 
Exemestane Adjuvant Therapies for Premenopausal Women with Endocrine Responsive 
Breast Cancer Tamoxifen versus Ovarian function suppression + tamoxifen versus 
Ovarian function suppression + exemestane</FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Christine Armetta, BS, MBA, C<st1:PersonName w:st="on">CR</st1:PersonName> P</FONT> 
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
06-017:</STRONG>&nbsp; C40302/ Endocrine Therapy with or without Inhibition of 
EGF and HER2 Growth Factor Receptors: A Randomized, Double-Blind, Placebo 
Controlled Phase III Trial for Postmenopausal Women with Estrogen Receptor 
Positive Advanced Breast Cancer</FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Christine Armetta, BS, MBA, C<st1:PersonName w:st="on">CR</st1:PersonName> P </FONT>
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
07-023:</STRONG> NSABP Protocol B-42 / A Clinical Trial To Determine The 
Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing 
Five Years of Hormonal Therapy Consisting of An Aromatase Inhibitor (AI) or 
Tamoxifen Followed by An AI In Prolonging Disease-Free Survival In 
Postmenopausal Women With Hormone Receptor Positive Cancer</FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Mary Connelly, PA-C, C<st1:PersonName w:st="on">CR</st1:PersonName> P</FONT> 
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
08-009:</STRONG>&nbsp; BMS 163-131:&nbsp; A Randomized Phase 2 Study to Evaluate 
the Combinations of Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine 
in the Treatment of Metastatic Breast Cancer</FONT></P>
<P class=consenttext><FONT size=2><FONT face="Times New Roman, Times"><SPAN lang=EN-CA>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Principal 
Investigator:&nbsp; Robert Reilly, MD </SPAN></FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C, C<st1:PersonName w:st="on">CR</st1:PersonName> P </FONT>
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal></P>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
08-010:</STRONG> E PACCT-1 Program for the Assessment of Clinical Cancer Tests 
Trial Assigning Individualized Options for Treatment:&nbsp; The TAILORx 
Trial</FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Christine Armetta, BS, MBA </FONT>
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
08-017:</STRONG>&nbsp; NCCTG/N063D/ALTTO: Adjuvant Lapatinib 
and/or<BR>Trastuzumab Treatment Optimisation Study A randomized, multi-centre, 
open-label, phase III study of adjuvant lapatinib, trastuzumab, their sequence 
and their combination in patients with HER2/ErbB2 positive primary breast 
cancer</FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Christine Armetta, BS, MBA, C<st1:PersonName w:st="on">CR</st1:PersonName> P </FONT>
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
08-015:</STRONG>&nbsp; A Double Blind Phase III Trial of Doxorubicin and 
Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in patients 
with Lymph Node Positive and High Risk Lymph Node Negative Breast 
Cancer</FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Christine Armetta, BS, MBA, C<st1:PersonName w:st="on">CR</st1:PersonName> P </FONT>
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
09-006</STRONG><STRONG>:</STRONG>&nbsp; Wyeth Research Protocol No. 
3144A2-3003-WW A Phase III randomized open label study of Neratinib vs. 
Lapatinib plus Capecitabine for the treatment of ErbB-2-positive locally 
advanced or metastatic breast cancer</FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Christine Armetta, BS, MBA, C<st1:PersonName w:st="on">CR</st1:PersonName> P </FONT>
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
09-008:</STRONG>&nbsp;&nbsp; 3144A2-3004-WW Wyeth A Randomized Double-blind 
Placebo-Controlled Trial of Neratinib (HKI-272) After Trastuzumab in Women With 
Early-Stage HER-2/neu Overexpressed/Amplified Breast Cancer</FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Christine Armetta, BS, MBA, C<st1:PersonName w:st="on">CR</st1:PersonName> P </FONT>
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
09-017:</STRONG>&nbsp; Cognitive Function Substudy (ANZ 0701 Co-SOFT)</FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Christine Armetta, BS, MBA, C<st1:PersonName w:st="on">CR</st1:PersonName> P </FONT>
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2>&nbsp;</FONT><FONT face="Times New Roman, Times" size=2>&nbsp;</FONT></P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
10-005:</STRONG>&nbsp;&nbsp; NSABP B43 A phase III Clinical trial comparing 
Trastuzumab given concurrently with radiation therapy and radiation therapy 
alone for women with HER2 positive ductal carcinoma in situ resected by 
lumpectomy</FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Christine Armetta, BS, MBA, C<st1:PersonName w:st="on">CR</st1:PersonName> P </FONT>
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, <FONT   color=#000000>email</FONT>&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal></FONT></FONT>
<HR>
<STRONG><FONT color=#2e6481>CERVIX<BR></FONT></STRONG><FONT color=#000000>Presently there are no protocols available at St. Mary Medical 
Center 
<HR>
</FONT><FONT color=#2e6481><STRONG>CHEMOPREVENTION<BR></STRONG></FONT><FONT color=#000000>Presently there are no protocols available at St. Mary Medical 
Center 
<HR>
</FONT><FONT color=#2e6481><STRONG>COLORECTAL</STRONG></FONT> </FONT></FONT>
<HR>
<STRONG><FONT color=#2e6481>CERVIX<BR></FONT></STRONG><FONT color=#000000>Presently there are no protocols available at St. Mary Medical 
Center 
<HR>
</FONT><FONT color=#2e6481><STRONG>CHEMOPREVENTION<BR></STRONG></FONT><FONT color=#000000>Presently there are no protocols available at St. Mary Medical 
Center 
<HR>
</FONT><FONT color=#2e6481><STRONG>COLORECTAL</STRONG></FONT> <FONT color=#000000>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
06-005</STRONG>: A Randomized Phase III Study Comparing 5-FU, Leucovorin and 
Oxaliplatin vs. 5-FU, Leucovorin, Oxaliplatin and Beacizumab in Patients with 
Stage II Colon Cancer at high Risk for Recurrence to Determine Prospectively the 
Prognostic Value of Molecular Markers</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Jennifer Torres, RN</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
09-013</STRONG>:&nbsp; C80405 A Phase III Trial of Irinotecan / 5-FU / 
Leucovorin or Oxaliplatin / 5-FU / Leucovorin with Bevacizumab, or Cetuximab 
(C225), or with the Combination of Bevacizumab and Cetuximab for Patients with 
Untreated Metastatic Adenocarcinoma of the Colon or Rectum</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Jennifer Torres, RN</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman"><FONT size=2><STRONG>SMMC 
10-001:</STRONG>&nbsp;&nbsp; BMS CA196004 A Randomized, Double-Blind, Phase II 
Trial of CT-322 (BMS-844203) plus Irinotecan, 5-FU and Leucovorin (FOLFIRI) 
versus Bevacizumab plus FOLFIRI as Second-Line Treatment for Metastatic 
Colorectal Cancer</FONT></FONT></P>
<UL type=disc>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD </FONT>
  <LI class=MsoNormal><FONT face="Times New Roman" size=2>Clinical 
  Coordinator:&nbsp;&nbsp; Jennifer Torres, RN</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT>
<P><FONT color=#000000>
<HR>
</FONT>
<P><STRONG><FONT color=#2e6481>ENDOMETRIAL</FONT></STRONG></P>
<P>Presently there are no protocols available at St. Mary Medical Center </P>
<P>
<HR>
<BR><STRONG><FONT color=#2e6481>GASTRIC OR 
GASTROSOPHAGEAL</FONT><BR></STRONG><FONT color=#000000>Presently there are no 
protocols available at St. Mary Medical Center </FONT>
<P>
<HR>

<P><FONT color=#000000><FONT color=#004080><STRONG>HEAD AND 
NECK/LARYNX</STRONG><BR></FONT>Presently there are no protocols available at St. 
Mary Medical Center </FONT>
<P><FONT color=#000000>
<HR>
<BR><STRONG><FONT color=#2e6481>LEUKEMIA</FONT></STRONG><BR>Presently there are 
no protocols available at St. Mary Medical Center </FONT>
<P><FONT color=#000000></P></FONT></P></FONT>
</FONT></FONT></FONT></FONT>
<HR>
<FONT color=#2e6481><STRONG>LUNG</STRONG></FONT> <FONT color=#000000>
<P class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2><STRONG>SMMC 
07-017:</STRONG>&nbsp; GSK1572932A Antigen-Specific Cancer<BR>Immunotherapeutic 
as adjuvant therapy in patients with Non-Small Cell Lung Cancer: A double-blind, 
randomized, placebo-controlled Phase <FONT face="Times New Roman, Times">III 
study to assess the efficacy of recMAGE-A3 + <st1:PersonName w:st="on">AS</st1:PersonName> 15 Antigen-Specific Cancer Immunotherapeutic as 
adjuvant therapy in patients with resectable MAGE-A3-positive Non-Small Cell 
Lung Cancer</FONT></FONT></FONT></P>
<UL>
  <LI>
  <DIV class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2><SPAN   lang=EN-CA><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD</FONT> </SPAN></FONT></FONT></DIV>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
07-021:</STRONG>&nbsp; E1505 / A Phase III Randomized Trial of Adjuant 
Chemotherpay With or Without Bevacizumab for Patients With Completely Reseacted 
Stage IB (<U>&gt;</U> 4cm) - IIIA Non-Small Cell Lung Cancer 
(NSCLC)</FONT></P><FONT face="Times New Roman, Times"><FONT size=2><SPAN lang=EN-CA><FONT size=2>
<UL>
  <LI>
  <DIV class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2><SPAN   lang=EN-CA><FONT face="Times New Roman, Times" size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD</FONT> 
  </SPAN></FONT></FONT></DIV></FONT></SPAN></FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL></FONT></SPAN></FONT></FONT>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL></FONT></SPAN></FONT></FONT>
<LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C</FONT> 
<LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A href="mailto:researchinstitute@stmaryhealthcare.org"><FONT face="Times New Roman, Times" color=#0000ff size=2>researchinstitute@stmaryhealthcare.org</FONT></A>
<UL></UL></FONT></SPAN></SPAN></FONT></FONT>
<LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C</FONT> 
<LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A href="mailto:researchinstitute@stmaryhealthcare.org"><FONT face="Times New Roman, Times" color=#0000ff size=2>researchinstitute@stmaryhealthcare.org</FONT></A> 
<UL></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
07-025:</STRONG>&nbsp; Abraxis CA031:&nbsp; Randomized, Phase III Trial of 
ABI-007 and Carboplatin Compared with Taxol® and Carboplatin as First-Line 
Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)</FONT></P>
<UL>
  <LI>
  <DIV class=consenttext><FONT face="Times New Roman, Times"><FONT size=2><SPAN   lang=EN-CA><SPAN lang=EN-CA><FONT size=2>Principal Investigator:&nbsp; Robert 
  Reilly, MD</FONT> </SPAN></SPAN></FONT></FONT></DIV>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; <A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   color=#0000ff>researchinstitute@stmaryhealthcare.org</FONT></A></FONT></FONT></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
07-026:</STRONG>&nbsp; RTOG (0617), NCCTG (N0628), CALGB (30609)/ A Randomized 
Phase III Comparison of Standard- Dose (60Gy) versus High-dose (74Gy) Conformal 
Radiotherapy with Concurrent and Consolidation Carboplatin / Paclitaxel in 
Patients with Stage IIIA / IIIB Non-Small Cell Lung Cancer</FONT></P>
<UL>
  <LI>
  <DIV class=consenttext><FONT face="Times New Roman, Times"><FONT size=2><SPAN   lang=EN-CA><SPAN lang=EN-CA><FONT size=2>Principal Investigator:&nbsp; Robert 
  Reilly, MD</FONT> </SPAN></SPAN></FONT></FONT></DIV>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
06-017:</STRONG>&nbsp; C40302/ Endocrine Therapy with or without Inhibition of 
EGF and HER2 Growth Factor Receptors: A Randomized, Double-Blind, Placebo 
Controlled Phase III Trial for Postmenopausal Women with Estrogen Receptor 
Positive Advanced Breast Cancer</FONT></P>
<UL>
  <LI>
  <DIV class=consenttext><FONT face="Times New Roman, Times"><FONT size=2><SPAN   lang=EN-CA><SPAN lang=EN-CA><FONT size=2>Principal Investigator:&nbsp; Robert 
  Reilly, MD</FONT> </SPAN></SPAN></FONT></FONT></DIV>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C, C<st1:PersonName w:st="on">CR</st1:PersonName> P</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
09-012:</STRONG>&nbsp;&nbsp; E1508 A Randomized Phase II Study of Cisplatin and 
Etoposide In Combination with Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB 
IMC-A12 for Patients with Extensive Stage Small Cell Lung Cancer</FONT></P>
<UL>
  <LI>
  <DIV class=consenttext><FONT face="Times New Roman, Times"><FONT size=2><SPAN   lang=EN-CA><SPAN lang=EN-CA><FONT size=2>Principal Investigator:&nbsp; Robert 
  Reilly, MD</FONT> </SPAN></SPAN></FONT></FONT></DIV>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C, C<st1:PersonName w:st="on">CR</st1:PersonName> P</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL>
<P></FONT><FONT color=#000000>
<P>
<HR>

<P><BR><STRONG><FONT color=#2e6481>LYMPHOMA</FONT></STRONG><BR>Presently there 
are no protocols available at St. Mary Medical Center </P>
<P>
<HR>
<BR><STRONG><FONT color=#2e6481>MELANOMA</FONT></STRONG> 
<P>Presently there are no protocols available at St. Mary Medical Center <A href="mailto:csalerno@stmaryhealthcare.org"><STRONG></STRONG></A></P>
<P></FONT><FONT color=#000000>
<HR>
<STRONG><FONT color=#2e6481>MULTIPLE MYELOMA</FONT></STRONG><BR>Presently there 
are no protocols available at St. Mary Medical Center </FONT>
<P><FONT color=#000000>
<HR>
<STRONG><FONT color=#2e6481>OVARIAN<BR></FONT></STRONG>Presently there are no 
protocols available at St. Mary Medical Center </FONT>
<P><FONT color=#000000></P></FONT></P></FONT>
</FONT></FONT></FONT></FONT>
<HR>
<STRONG><FONT color=#2e6481>PANCREATIC</FONT></STRONG> <BR><FONT color=#000000>
<P class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times"><B>SMMC 
09-007:</B>&nbsp;&nbsp; Abraxis CA046 A randomized phase III study of weekly 
ABI-007 plus Gemcitabine vs. Gemcitabine alone in patients with metastatic 
adenocarcinoma of the Pancreas</FONT></FONT></P>
<UL>
  <LI>
  <DIV class=consenttext><FONT size=2><FONT face="Times New Roman, Times"><SPAN   lang=EN-CA><SPAN lang=EN-CA><SPAN lang=EN-CA><FONT size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD</FONT> 
  </SPAN></SPAN></SPAN></FONT></FONT></DIV>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Mary Connelly, PA-C, C<st1:PersonName w:st="on">CR</st1:PersonName> P</FONT> 
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL></FONT>
<P>
<P><FONT color=#000000></P></FONT></P></FONT>
</FONT></FONT></FONT></FONT>
<HR>
<FONT color=#2e6481><STRONG>PROSTATE</STRONG></FONT> <BR><FONT color=#000000>
<P class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2><B>SMMC 
08-013</B>:&nbsp; RTOG 0415 A PH<st1:PersonName w:st="on">AS</st1:PersonName> E III RANDOMIZED STUDY OF HYPOFRACTIONATED 3D-<st1:PersonName w:st="on">CR</st1:PersonName> T/IMRT VERSUS CONVENTIONALLY FRACTIONATED 3D-<st1:PersonName w:st="on">CR</st1:PersonName> T/IMRT IN PATIENTS WITH FAVORABLE-RISK PROSTATE 
CANCER</FONT></FONT></P>
<UL>
  <LI>
  <DIV class=consenttext><FONT face="Times New Roman, Times"><FONT size=2><SPAN   lang=EN-CA><SPAN lang=EN-CA><SPAN lang=EN-CA><FONT size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD</FONT> 
  </SPAN></SPAN></SPAN></FONT></FONT></DIV>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Jennifer Torres, RN</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; <A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   color=#0000ff>researchinstitute@stmaryhealthcare.org</FONT></A></FONT></FONT></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2><B>SMMC 
08-014</B>: RTOG 0534 A Phase III trial of short term androgen deprivation with 
pelvic lymph node or prostate bed only radiotherapy (SPORT) in prostate cancer 
patients with a rising PSA after radical prostatectomy</FONT></FONT></P>
<UL>
  <LI>
  <DIV class=consenttext><FONT face="Times New Roman, Times"><FONT size=2><SPAN   lang=EN-CA><SPAN lang=EN-CA><SPAN lang=EN-CA><FONT size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD</FONT> 
  </SPAN></SPAN></SPAN></FONT></FONT></DIV>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Jennifer Torres, RN</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; <A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   color=#0000ff>researchinstitute@stmaryhealthcare.org</FONT></A></FONT></FONT></LI></UL>
<P class=MsoNormal>&nbsp;</P>
<P class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2><B>SMMC 
09-016:</B>&nbsp; RTOG 0815/SMMC 09016 A phase III prospective randomized trial 
of dose-escalated radiotherapy with or without short-term androgen deprivation 
therapy for patients with intermediate-risk prostate cancer</FONT></FONT></P>
<UL>
  <LI>
  <DIV class=consenttext><FONT face="Times New Roman, Times"><FONT size=2><SPAN   lang=EN-CA><SPAN lang=EN-CA><SPAN lang=EN-CA><FONT size=2>Principal 
  Investigator:&nbsp; Robert Reilly, MD</FONT> 
  </SPAN></SPAN></SPAN></FONT></FONT></DIV>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Jennifer Torres, RN</FONT> 
  <LI class=MsoNormal><FONT face="Times New Roman, Times"><FONT size=2>For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email&nbsp; </FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times"   size=2>researchinstitute@stmaryhealthcare.org</FONT></A></LI></UL></FONT><FONT color=#000000>
<HR>
</FONT></FONT><FONT color=#2e6481><STRONG></STRONG>
<P><FONT color=#000000><STRONG><FONT color=#2e6481>RECTAL</FONT></STRONG></FONT></P><FONT size=3><FONT color=#000000><FONT face="Times New Roman">
<P class=MsoNormal><FONT face="Times New Roman, Times" size=2><STRONG>SMMC 
05-005:</STRONG>&nbsp; NSABP R04 A clinical trial comparing preoperative 
radiation therapy and Capecitabine with preoperative radiation therapy and 
continuous intravenous infusion of 5FU in the treatment of patients with 
operable carcinoma of the rectum</FONT></P>
<UL>
  <LI>
  <DIV class=consenttext><FONT size=2><FONT face="Times New Roman, Times"><SPAN   lang=EN-CA><SPAN lang=EN-CA><SPAN lang=EN-CA><SPAN lang=EN-CA><FONT   size=2>Principal Investigator:&nbsp; Robert Reilly, MD</FONT> 
  </SPAN></SPAN></SPAN></SPAN></FONT></FONT></DIV>
  <LI class=MsoNormal><FONT face="Times New Roman, Times" size=2>Clinical 
  Coordinators:&nbsp;&nbsp; Jennifer Torres, RN</FONT> 
  <LI class=MsoNormal><FONT size=2><FONT face="Times New Roman, Times">For 
  a<st1:PersonName w:st="on">dd</st1:PersonName> itional information, email<STRONG>&nbsp; 
  </STRONG></FONT></FONT><A   href="mailto:researchinstitute@stmaryhealthcare.org"><FONT   face="Times New Roman, Times" color=#0000ff   size=2><STRONG>researchinstitute@stmaryhealthcare.org</STRONG></FONT></A></LI></UL>
<P class=MsoNormal>
<HR>
</FONT></FONT></FONT>
<P><FONT color=#000000><STRONG><FONT color=#2e6481>BECOMING A RESEARCH 
VOLUNTEER:<BR></FONT></STRONG>Someday, you or a family member may want to take 
part in a research study. If this happens, the information here may help you 
make the right decision.<BR><STRONG><EM>What Is Research?</EM></STRONG> 
</FONT></P>
<UL>
  <LI><FONT color=#000000>Research is a study that is done to answer a question. 
  </FONT>
  <LI><FONT color=#000000>Scientists do research because they don’t know for 
  sure what works best to help you. They are working to determine the answer as 
  to what is best.</FONT> 
  <LI><FONT color=#000000>Some other words that describe research are clinical 
  trial, protocol, survey, or experiment. </FONT>
  <LI><FONT color=#000000>Research is not the same as treatment. 
<BR></FONT></LI></UL>
<P><FONT color=#000000><EM><STRONG>Why Is Research Important?</STRONG></EM> 
<BR>Research has led to important discoveries that make our lives better. Some 
examples are:</FONT> </P>
<UL>
  <LI><FONT color=#000000>New drugs to treat cancer, diabetes, and other 
  diseases </FONT>
  <LI><FONT color=#000000>Ultrasound, X-ray machines, and diagnostic tests 
  </FONT>
  <LI><FONT color=#000000>Vaccines </FONT>
  <LI><FONT color=#000000>Ways to stop smoking </FONT>
  <LI><FONT color=#000000>Improved medical procedures </FONT></LI></UL><FONT color=#000000>
<P><BR><STRONG><EM>These are some questions that you should ask before you agree 
to participate in a research study:</EM></STRONG> </P>
<UL>
  <LI><FONT color=#000000>Why is the research being done?&nbsp;</FONT> 
  <LI><FONT color=#000000>What question are you trying to answer?</FONT> 
  <LI><FONT color=#000000>What will be done to me as part of the 
  research?</FONT> 
  <LI><FONT color=#000000>How will I benefit from the research?</FONT> 
  <LI><FONT color=#000000>What other options do I have?</FONT> 
  <LI><FONT color=#000000>Could the research hurt me?</FONT> 
  <LI><FONT color=#000000>Have other studies like this one been done?</FONT> 
  <LI><FONT color=#000000>What will the researcher do with my 
  information?</FONT> 
  <LI><FONT color=#000000>Will the research cost me anything?</FONT> 
  <LI><FONT color=#000000>Who pays if I’m unexpectedly injured in the 
  study?</FONT> 
  <LI><FONT color=#000000>How long will the study last?&nbsp; </FONT>
  <LI><FONT color=#000000>What do I have to do as far as office visits, 
  medications, medical tests?</FONT> 
  <LI><FONT color=#000000>What happens if I decide to leave the study 
  early?</FONT> 
  <LI><FONT color=#000000>Who should I call if I have a question about the 
  research?</FONT></LI></UL>
<P>&nbsp;</P>
<P></FONT></FONT><FONT color=#000000><STRONG><EM>Points to 
Consider</EM></STRONG> </FONT></P></FONT></FONT><FONT color=#000000><STRONG><EM>Points to 
Consider</EM></STRONG> </FONT></P></FONT></FONT><FONT color=#000000><STRONG><EM>Points to Consider</EM></STRONG> </FONT>
</FONT></FONT><FONT color=#000000><STRONG><EM>Points to 
Consider</EM></STRONG> </FONT></FONT></FONT><FONT color=#000000><STRONG><EM>Points to Consider</EM></STRONG> 
</FONT></FONT></FONT><FONT color=#000000><STRONG><EM>Points to 
Consider</EM></STRONG> </FONT>
<UL>
  <LI><FONT color=#000000>A research study may or may not help you personally. 
  </FONT>
  <LI><FONT color=#000000>In the future, the results could help others who have 
  a health problem. </FONT>
  <LI><FONT color=#000000>Taking part in research is voluntary. </FONT></LI></UL>
<P><FONT color=#000000>Before you decide to become a research volunteer, get the 
facts: </FONT></P>
<UL>
  <LI><FONT color=#000000>Know what you’re getting into. </FONT>
  <LI><FONT color=#000000>Ask questions. </FONT>
  <LI><FONT color=#000000>Learn as much as you can. </FONT>
  <LI><FONT color=#000000>Know the pros and cons. </FONT></LI></UL>
<P><BR><FONT color=#000000>&nbsp;<BR><STRONG><EM>Would you like to participate 
in a Clinical Trial?</EM></STRONG> <BR>Are you looking for therapy options for 
your illness? If you would like to be contacted regarding current or future 
clinical research trials that are attempting to treat a medical condition or 
improve the quality of life for individuals like yourself and others 
please&nbsp;send&nbsp;email <A href="mailto:kdevine@stmaryhealthcare.org">kdevine@stmaryhealthcare.org</A> 
.&nbsp;Your confidential information will be maintained in our Research Center 
database and we will contact you with information about trials for which you may 
qualify as they become available. </FONT></P>
<P><FONT color=#000000>Email Kim Devine <A href="mailto:kdevine@stmaryhealthcare.org"><FONT color=#000000>kdevine@stmaryhealthcare.org</FONT></A></FONT><FONT color=#000000>&nbsp;&nbsp;with the following information<BR><BR>First 
Name:&nbsp;&nbsp; <BR>Middle Initial:&nbsp; <BR>Last Name:&nbsp; <BR>Street 
Address:&nbsp; <BR>Apartment or Suite:&nbsp; <BR>City:&nbsp; State:&nbsp; 
Zip:&nbsp; <BR>Home Phone:&nbsp;&nbsp; <BR>E-mail Address: <BR>Gender:&nbsp; 
<BR>Date of Birth:&nbsp;&nbsp; -&nbsp; -&nbsp; <BR>Best time to 
call&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <BR>Have you ever been a 
patient at the St. Mary Medical Center?&nbsp; <BR>List Your Current Medical 
Conditions:<BR>&nbsp;<BR>&nbsp;&nbsp; <BR>&nbsp;<BR>Your confidential 
information will only be used to notify you by letter regarding a clinical 
research trial which may potentially be of interest to you. Access to your 
confidential information will be limited to selected members of the St. Mary 
Research Center. To be removed from this list, please notify us in writing at 
St. Mary Medical Center, Department of Research, 1201 Langhorne-Newtown Rd. 
Langhorne, PA&nbsp; 19047, or by email to </FONT><A href="mailto:kdevine@stmaryhealthcare.org"><FONT color=#000000>kdevine@stmaryhealthcare.org</FONT></A><FONT color=#000000>.&nbsp;&nbsp;&nbsp; </FONT></P>
<P>
<TABLE cellSpacing=3 cellPadding=3 width="90%" bgColor=#e6e6e6>
  <TBODY>
  <TR>
    <TD>
      <P align=center>&nbsp;<STRONG><FONT size=3>Institutional Review Board: 
      Protecting Human Subjects in Research</FONT></STRONG> </P>
      <P><EM>Institution Review Boards (IRB) are established to ensure the 
      rights and welfare of people who choose to participate in clinical trials 
      both before and during their trial participation.&nbsp; The IRB is also 
      responsible for making sure that the research is performed in accordance 
      with federal, state, and local regulations and institutional policies when 
      testing investigational drugs or medical devices.&nbsp; These impartial 
      review panels assess the risks and benefits of each study trial to 
      minimize and fairly disclose risk to study participants. </EM></P>
      <P><EM>St. Mary Medical Center has two IRBs.&nbsp; IRB #2 reviews all 
      Oncology clinical trials, and IRB #1 reviews all other trial 
      protocols.&nbsp; Both IRBs are free standing.&nbsp; That is, they are not 
      regulated by any other group within the hospital.&nbsp; The Institutional 
      Review Boards of St. Mary Medical Center are comprised of members from 
      both scientific and non-scientific backgrounds.&nbsp; Membership consists 
      of staff physicians in various areas of expertise, risk management 
      specialists, and representatives of the local community.&nbsp; Priority is 
      placed on a membership of diversity to best serve the interests and safety 
      of all study participants. </EM></P>
      <P><EM>St. Mary Medical Center and its IRB are committed to being a 
      foremost clinical research center where standards of care are elevated 
      both now and in the future.&nbsp; If you are interested in being 
      considered for membership on this committee, please contact <A       href="mailto:ldemarco@stmaryhealthcare.org">Lori DeMarco, </A>IRB Office 
      at 215-710-6449.</EM></P></TD></TR></TBODY></TABLE></P>
<UL></UL>
<P><BR><FONT color=#000000>&nbsp;<BR><STRONG><EM>Would you like to participate 
in a Clinical Trial?</EM></STRONG> <BR>Are you looking for therapy options for 
your illness? If you would like to be contacted regarding current or future 
clinical research trials that are attempting to treat a medical condition or 
improve the quality of life for individuals like yourself and others 
please&nbsp;send&nbsp;email <A href="mailto:kdevine@stmaryhealthcare.org">kdevine@stmaryhealthcare.org</A> 
.&nbsp;Your confidential information will be maintained in our Research Center 
database and we will contact you with information about trials for which you may 
qualify as they become available. </FONT></P>
<P><FONT color=#000000>Email Kim Devine <A href="mailto:kdevine@stmaryhealthcare.org"><FONT color=#000000>kdevine@stmaryhealthcare.org</FONT></A></FONT><FONT color=#000000>&nbsp;&nbsp;with the following information<BR><BR>First 
Name:&nbsp;&nbsp; <BR>Middle Initial:&nbsp; <BR>Last Name:&nbsp; <BR>Street 
Address:&nbsp; <BR>Apartment or Suite:&nbsp; <BR>City:&nbsp; State:&nbsp; 
Zip:&nbsp; <BR>Home Phone:&nbsp;&nbsp; <BR>E-mail Address: <BR>Gender:&nbsp; 
<BR>Date of Birth:&nbsp;&nbsp; -&nbsp; -&nbsp; <BR>Best time to 
call&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <BR>Have you ever been a 
patient at the St. Mary Medical Center?&nbsp; <BR>List Your Current Medical 
Conditions:<BR>&nbsp;<BR>&nbsp;&nbsp; <BR>&nbsp;<BR>Your confidential 
information will only be used to notify you by letter regarding a clinical 
research trial which may potentially be of interest to you. Access to your 
confidential information will be limited to selected members of the St. Mary 
Research Center. To be removed from this list, please notify us in writing at 
St. Mary Medical Center, Department of Research, 1201 Langhorne-Newtown Rd. 
Langhorne, PA&nbsp; 19047, or by email to </FONT><A href="mailto:kdevine@stmaryhealthcare.org"><FONT color=#000000>kdevine@stmaryhealthcare.org</FONT></A><FONT color=#000000>.&nbsp;&nbsp;&nbsp; </FONT></P>
<P>
<TABLE cellSpacing=3 cellPadding=3 width="90%" bgColor=#e6e6e6>
  <TBODY>
  <TR>
    <TD>
      <P align=center>&nbsp;<STRONG><FONT size=3>Institutional Review Board: 
      Protecting Human Subjects in Research</FONT></STRONG> </P>
      <P><EM>Institution Review Boards (IRB) are established to ensure the 
      rights and welfare of people who choose to participate in clinical trials 
      both before and during their trial participation.&nbsp; The IRB is also 
      responsible for making sure that the research is performed in accordance 
      with federal, state, and local regulations and institutional policies when 
      testing investigational drugs or medical devices.&nbsp; These impartial 
      review panels assess the risks and benefits of each study trial to 
      minimize and fairly disclose risk to study participants. </EM></P>
      <P><EM>St. Mary Medical Center has two IRBs.&nbsp; IRB #2 reviews all 
      Oncology clinical trials, and IRB #1 reviews all other trial 
      protocols.&nbsp; Both IRBs are free standing.&nbsp; That is, they are not 
      regulated by any other group within the hospital.&nbsp; The Institutional 
      Review Boards of St. Mary Medical Center are comprised of members from 
      both scientific and non-scientific backgrounds.&nbsp; Membership consists 
      of staff physicians in various areas of expertise, risk management 
      specialists, and representatives of the local community.&nbsp; Priority is 
      placed on a membership of diversity to best serve the interests and safety 
      of all study participants. </EM></P>
      <P><EM>St. Mary Medical Center and its IRB are committed to being a 
      foremost clinical research center where standards of care are elevated 
      both now and in the future.&nbsp; If you are interested in being 
      considered for membership on this committee, please contact <A       href="mailto:ldemarco@stmaryhealthcare.org">Lori DeMarco, </A>IRB Office 
      at 215-710-6449.</EM></P></TD></TR></TBODY></TABLE></P></LI></UL>
<P><BR><FONT color=#000000>&nbsp;<BR><STRONG><EM>Would you like to participate 
in a Clinical Trial?</EM></STRONG> <BR>Are you looking for therapy options for 
your illness? If you would like to be contacted regarding current or future 
clinical research trials that are attempting to treat a medical condition or 
improve the quality of life for individuals like yourself and others 
please&nbsp;send&nbsp;email <A href="mailto:kdevine@stmaryhealthcare.org">kdevine@stmaryhealthcare.org</A> 
.&nbsp;Your confidential information will be maintained in our Research Center 
database and we will contact you with information about trials for which you may 
qualify as they become available. </FONT></P>
<P><FONT color=#000000>Email Kim Devine <A href="mailto:kdevine@stmaryhealthcare.org"><FONT color=#000000>kdevine@stmaryhealthcare.org</FONT></A></FONT><FONT color=#000000>&nbsp;&nbsp;with the following information<BR><BR>First 
Name:&nbsp;&nbsp; <BR>Middle Initial:&nbsp; <BR>Last Name:&nbsp; <BR>Street 
Address:&nbsp; <BR>Apartment or Suite:&nbsp; <BR>City:&nbsp; State:&nbsp; 
Zip:&nbsp; <BR>Home Phone:&nbsp;&nbsp; <BR>E-mail Address: <BR>Gender:&nbsp; 
<BR>Date of Birth:&nbsp;&nbsp; -&nbsp; -&nbsp; <BR>Best time to 
call&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <BR>Have you ever been a 
patient at the St. Mary Medical Center?&nbsp; <BR>List Your Current Medical 
Conditions:<BR>&nbsp;<BR>&nbsp;&nbsp; <BR>&nbsp;<BR>Your confidential 
information will only be used to notify you by letter regarding a clinical 
research trial which may potentially be of interest to you. Access to your 
confidential information will be limited to selected members of the St. Mary 
Research Center. To be removed from this list, please notify us in writing at 
St. Mary Medical Center, Department of Research, 1201 Langhorne-Newtown Rd. 
Langhorne, PA&nbsp; 19047, or by email to </FONT><A href="mailto:kdevine@stmaryhealthcare.org"><FONT color=#000000>kdevine@stmaryhealthcare.org</FONT></A><FONT color=#000000>.&nbsp;&nbsp;&nbsp; </FONT></P>
<P>
<TABLE cellSpacing=3 cellPadding=3 width="90%" bgColor=#e6e6e6>
  <TBODY>
  <TR>
    <TD>
      <P align=center>&nbsp;<STRONG><FONT size=3>Institutional Review Board: 
      Protecting Human Subjects in Research</FONT></STRONG> </P>
      <P><EM>Institution Review Boards (IRB) are established to ensure the 
      rights and welfare of people who choose to participate in clinical trials 
      both before and during their trial participation.&nbsp; The IRB is also 
      responsible for making sure that the research is performed in accordance 
      with federal, state, and local regulations and institutional policies when 
      testing investigational drugs or medical devices.&nbsp; These impartial 
      review panels assess the risks and benefits of each study trial to 
      minimize and fairly disclose risk to study participants. </EM></P>
      <P><EM>St. Mary Medical Center has two IRBs.&nbsp; IRB #2 reviews all 
      Oncology clinical trials, and IRB #1 reviews all other trial 
      protocols.&nbsp; Both IRBs are free standing.&nbsp; That is, they are not 
      regulated by any other group within the hospital.&nbsp; The Institutional 
      Review Boards of St. Mary Medical Center are comprised of members from 
      both scientific and non-scientific backgrounds.&nbsp; Membership consists 
      of staff physicians in various areas of expertise, risk management 
      specialists, and representatives of the local community.&nbsp; Priority is 
      placed on a membership of diversity to best serve the interests and safety 
      of all study participants. </EM></P>
      <P><EM>St. Mary Medical Center and its IRB are committed to being a 
      foremost clinical research center where standards of care are elevated 
      both now and in the future.&nbsp; If you are interested in being 
      considered for membership on this committee, please contact <A       href="mailto:ldemarco@stmaryhealthcare.org">Lori DeMarco, </A>IRB Office 
      at 215-710-6449.</EM></P></TD></TR></TBODY></TABLE></P>
<UL></UL>
<P><BR><FONT color=#000000>&nbsp;<BR><STRONG><EM>Would you like to participate 
in a Clinical Trial?</EM></STRONG> <BR>Are you looking for therapy options for 
your illness? If you would like to be contacted regarding current or future 
clinical research trials that are attempting to treat a medical condition or 
improve the quality of life for individuals like yourself and others 
please&nbsp;send&nbsp;email <A href="mailto:kdevine@stmaryhealthcare.org">kdevine@stmaryhealthcare.org</A> 
.&nbsp;Your confidential information will be maintained in our Research Center 
database and we will contact you with information about trials for which you may 
qualify as they become available. </FONT></P>
<P><FONT color=#000000>Email Kim Devine <A href="mailto:kdevine@stmaryhealthcare.org"><FONT color=#000000>kdevine@stmaryhealthcare.org</FONT></A></FONT><FONT color=#000000>&nbsp;&nbsp;with the following information<BR><BR>First 
Name:&nbsp;&nbsp; <BR>Middle Initial:&nbsp; <BR>Last Name:&nbsp; <BR>Street 
Address:&nbsp; <BR>Apartment or Suite:&nbsp; <BR>City:&nbsp; State:&nbsp; 
Zip:&nbsp; <BR>Home Phone:&nbsp;&nbsp; <BR>E-mail Address: <BR>Gender:&nbsp; 
<BR>Date of Birth:&nbsp;&nbsp; -&nbsp; -&nbsp; <BR>Best time to 
call&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <BR>Have you ever been a 
patient at the St. Mary Medical Center?&nbsp; <BR>List Your Current Medical 
Conditions:<BR>&nbsp;<BR>&nbsp;&nbsp; <BR>&nbsp;<BR>Your confidential 
information will only be used to notify you by letter regarding a clinical 
research trial which may potentially be of interest to you. Access to your 
confidential information will be limited to selected members of the St. Mary 
Research Center. To be removed from this list, please notify us in writing at 
St. Mary Medical Center, Department of Research, 1201 Langhorne-Newtown Rd. 
Langhorne, PA&nbsp; 19047, or by email to </FONT><A href="mailto:kdevine@stmaryhealthcare.org"><FONT color=#000000>kdevine@stmaryhealthcare.org</FONT></A><FONT color=#000000>.&nbsp;&nbsp;&nbsp; </FONT></P>
<P>
<TABLE cellSpacing=3 cellPadding=3 width="90%" bgColor=#e6e6e6>
  <TBODY>
  <TR>
    <TD>
      <P align=center>&nbsp;<STRONG><FONT size=3>Institutional Review Board: 
      Protecting Human Subjects in Research</FONT></STRONG> </P>
      <P><EM>Institution Review Boards (IRB) are established to ensure the 
      rights and welfare of people who choose to participate in clinical trials 
      both before and during their trial participation.&nbsp; The IRB is also 
      responsible for making sure that the research is performed in accordance 
      with federal, state, and local regulations and institutional policies when 
      testing investigational drugs or medical devices.&nbsp; These impartial 
      review panels assess the risks and benefits of each study trial to 
      minimize and fairly disclose risk to study participants. </EM></P>
      <P><EM>St. Mary Medical Center has two IRBs.&nbsp; IRB #2 reviews all 
      Oncology clinical trials, and IRB #1 reviews all other trial 
      protocols.&nbsp; Both IRBs are free standing.&nbsp; That is, they are not 
      regulated by any other group within the hospital.&nbsp; The Institutional 
      Review Boards of St. Mary Medical Center are comprised of members from 
      both scientific and non-scientific backgrounds.&nbsp; Membership consists 
      of staff physicians in various areas of expertise, risk management 
      specialists, and representatives of the local community.&nbsp; Priority is 
      placed on a membership of diversity to best serve the interests and safety 
      of all study participants. </EM></P>
      <P><EM>St. Mary Medical Center and its IRB are committed to being a 
      foremost clinical research center where standards of care are elevated 
      both now and in the future.&nbsp; If you are interested in being 
      considered for membership on this committee, please contact <A       href="mailto:ldemarco@stmaryhealthcare.org">Lori DeMarco, </A>IRB Office 
      at 215-710-6449.</EM></P></TD></TR></TBODY></TABLE></P></LI></BODY>


<br>

		
	
		
	
		
	
		
	
		
	
		
	
		
	
		
	
		
	 
 
<br></td>   
              </tr>
            </table></td>
        </tr>     
      </table></td>	  
  </tr>
</table>
<table width="100%" valign="top" border="0" cellpadding="0" cellspacing="0">
  <tr>
     <td valign="top" width="100%" align="center" style="background-image: url(images/footertile.gif); background-repeat: repeat-x; background-position: top left;">
	<!-- Begin NavBar Output  -  Version:  v0.79a 09/30/2006  -->
	
		<!-- Begin NavBar Bar #3 Content Output... -->
		<table  border="0" cellspacing="0" cellpadding="0" onclick="NavBar_deleteCookie();">
	<tr class="">
		<td class="" valign="middle" align="left"><img src="images/footer.gif" alt=""></td>
		<td class="" valign="middle" align="left" title=""><a href="Javascript: void(0);"  onClick="NavBar_setPLinkIDCookie('555565','');window.location.href='body.cfm?id=555565&oTopID=0';" class="">Legal Notice</a></td>
		<td class="" valign="middle" align="left" title="">&nbsp;|&nbsp;</td>
		<td class="" valign="middle" align="left" title=""><a href="Javascript: void(0);"  onClick="NavBar_setPLinkIDCookie('555557','');window.location.href='body.cfm?id=555557&oTopID=0';" class="">Contact Us</a></td>
	</tr>
</table>
	
		<!-- End NavBar Output -->
	 
</td>
    </tr>
</table>



</body>
</html>